Introduction {#sec1}
============

For nearly two decades, the concepts like "escape the flatland", "conformational restriction", and "scaffold hopping" have remained the major hallmarks of medicinal chemistry.^[@ref1]−[@ref3]^ The resulting shift from "traditional" drug design based mainly on (hetero)aromatic cores toward sp^3^-enriched, 3D-shaped templates prompted more sophisticated methodologies to produce medicinally relevant molecules. Nevertheless, as shown by a number of recent analyses, the majority of medicinal chemists do not easily accept novel synthetic methods and still prefer to use well-known, robust procedures in their synthetic planning.^[@ref4]^ Possible (and somewhat overlooked) design strategies to address this issue rely on the use of advanced building blocks, in many cases available from commercial sources. It is not surprising therefore that synthesis of three-dimensional building blocks with a high fraction of sp^3^-hybridized carbon atoms (Fsp^3^) has become a part of the industry.^[@ref5]^ The criteria for these compounds were recently reviewed by Goldberg et al. from AstraZeneca.^[@ref6]^ Low-molecular-weight spirocyclic motifs can be examples of such building blocks; in 2010, they were outlined as a class of compounds highly relevant to drug discovery by Carreira and co-workers.^[@ref7],[@ref8]^ As part of our ongoing efforts on design and synthesis of advanced building blocks for medicinal chemistry,^[@ref9]^ we turned our attention to pyrrolidines with a spirocyclic moiety attached at the α carbon atom of the heteroaliphatic ring (i.e., 1-azaspiro\[4.*n*\]alkanes and their hetera-substituted analogues). Derivatives of these building blocks are presented with highly potent compounds demonstrating a wide range of biological effects ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref10]^ Furthermore, over 5,000 1-azaspiro\[4.*n*\]alkane derivatives or their hetera-analogues with annotated biological activity were retrieved by a quick substructure search in the Reaxys database.^[@ref11]^

![Representative examples of biologically active 1-azaspiro\[4.*n*\]alkanes.](ao-2019-00896m_0012){#fig1}

In this work, we describe our synthetic efforts toward multigram preparation of the smallest spirocyclic α,α-disubstituted pyrrolidines **1a**--**1r** for our in-house medchem project as well as building block collection enhancement shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. Over the last 10 years, derivatives of the compounds **1a**--**1e**, **1i**, **1p**, and **1r** were broadly represented in patents, while other members of the series remained unknown to date ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

![The target spirocyclic pyrrolidines **1a**--**1r**.](ao-2019-00896m_0010){#fig2}

###### Reaxys Data for the Known Compounds of Type **1**

  entry   compound   no. of biologically active derivatives   no. of patents/papers   no. of syntheses described   known N-protected derivative(s)
  ------- ---------- ---------------------------------------- ----------------------- ---------------------------- ------------------------------------------------
  1       **1a**     11                                       14/0                    0                            Bn^[@ref12]^
  2       **1b**     15                                       7/0                     0                            Boc^[@ref13]^
  3       **1c**     7                                        4/1                     0                            Boc,^[@ref13]^ Ts^[@ref14]^
  4       **1d**     23                                       7/7                     2^[@ref15]^                  Boc,^[@ref13]^ Ts,^[@ref16]^ CO~2~Et^[@ref17]^
  5       **1e**     2                                        3/0                     1^[@ref13]^                  Boc,^[@ref13]^ CO~2~Et^[@ref17]^
  6       **1i**     5                                        12/0                    0                             
  7       **1p**     839                                      770/70                  1^[@ref18]^                   
  8       **1r**     81                                       69/11                   0                            Bn^[@ref19]^

Despite their well-documented biological activity, synthesis of these compounds is not described properly in the literature. In particular, only three spirocyclic pyrrolidines (i.e., **1d**, **1e**, and **1p**) were described as the free amines, and four more (**1a**--**1c** and **1r**) as the corresponding N-protected derivatives ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The known approaches to assemble the spirocyclic core of 1-azaspiro\[4.*n*\]alkanes and their hetera-analogues are summarized in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. The historically first and very straightforward approach was described for the preparation of the compound **1d** in 1957 (method A); it was based on the three-step synthetic sequence commencing from cyclic nitro compounds.^[@ref15]^ Since then, a number of alternative synthetic schemes were elaborated. In 2013, Perry and co-workers described a reductive cyclization of α-amino nitrile derivatives mediated by lithium di-*tert*-butyl biphenylide (LiDBB), which were made by double alkylation of aminoacetonitrile derivatives (method B).^[@ref13]^ In 2016, Um et al. developed an intermolecular Cu-catalyzed carboamination of cyclic vinylarenes with potassium *N*-carbamoyl-β-aminoethyltrifluoroborate (method C).^[@ref20]^ At the same time, Yu et al. applied the gold-catalyzed tandem reductive cycloisomerization of cyclic homopropargyl sulfonamides for the synthesis of *N*-tosyl-protected compound **1c** (method D).^[@ref14]^ In 2017, Skvorcova and co-workers studied a rearrangement of *N*-protected spirocyclic (cyclopropylmethyl)amines promoted with trifluoroacetic acid (method E).^[@ref17]^ A related approach was described by Shi et al.; it relied on the Au(I)-catalyzed reaction of methylenecyclopropanes with sulfonamides via a domino ring-opening--ring-closing--hydroamination sequence (method F).^[@ref16]^ The approach was illustrated by the synthesis of two examples of Ts-protected spiropyrrolidines.

![Known approaches A--G for the synthesis of spirocyclic α,α-disubstituted pyrrolidines.](ao-2019-00896m_0001){#fig3}

However, the aforementioned methods have their own drawbacks when their application for multigram (at least ∼20 g^6^) and cost-effective synthesis of building blocks is considered. These drawbacks include the use of uncommon, hazardous, or toxic reagents and/or catalysts, multistep reaction sequences, and/or limited substrate scope ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Herein, we have turned our attention to the method described by chemists from AstraZeneca ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}, G),^[@ref18]^ which relied on bromine-mediated cyclization of a cyclic homoallylamine derivative with subsequent catalytic debromination. In our hands, this synthetic sequence was reproduced at a 30 g scale with 27% overall yield (36% at the last step). Therefore, we considered this strategy as a starting point for further optimization.

###### Drawbacks of Existing Approaches to α,α-Disubstituted Spirocyclic Pyrrolidines

  entry   approach   major drawbacks
  ------- ---------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1       A          Lack of commercially available aliphatic low-molecular-weight nitro compounds. The in-house multigram synthesis of such compounds is not safe due to potential explosion hazard.
  2       B          The synthetic scheme is too long. The scale-up of LiDBB-promoted step is problematic. Toxic cyanide wastes are side products of the reaction.
  3       C          *N*-Carbamoyl-β-aminoethyl trifluoroborate is not available on multigram scale. The synthesis is limited only to aryl-fused systems.
  4       D          An expensive and hardly accessible Au (I) catalyst is used at high loading. Removal of the tosyl protective group is not convenient at a large scale.
  5       E          Harsh reaction conditions of the key step complicate scale-up and limit the substrate scope.
  6       F          Expensive and hardly accessible Ag (I) and Au (I) catalysts are used at high loading. Removal of the tosyl protective group is not convenient at a large scale.
  7       G          Moderate yield of the last step.

Results and Discussion {#sec2}
======================

The initial optimization of the literature method started with minor modifications of the reaction conditions. At the first step, simple refluxing of ketones **2b**--**2d** and benzylamine in toluene with a Dean--Stark trap for 1 h was used ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). This resulted in the formation of imines **3b**--**3d** in nearly quantitative yields, which could be used in the next step after removal of the solvent without any additional purification. For the second step, allylmagnesium bromide was replaced with more accessible allylmagnesium chloride (commercially available, 2 M in THF); thus, the solvent was also changed to THF. These minor modifications did not affect the yield of the products **4b**--**4d**, which exceeded 90% in all cases studied. Further steps of the reaction sequence (**4b**--**4d** → **6b**--**6d**) were performed in a one-pot manner, including subsequent addition of 40% aq HBr, Br~2~, and Et~3~N to a solution of **4b**--**4d** in CH~2~Cl~2~. We found this modification of the protocol to be more robust and convenient for scale-up as compared to the literature method (i.e., addition of in situ generated methanolic HBr, Br~2~, and aq K~2~CO~3~ to a solution of the substrate in MeOH--CH~2~Cl~2~). The crude products **6b**--**6d** were obtained in nearly quantitative yield with at least 90% purity.

![Synthesis of Spirocyclic Pyrrolidines (Approach I)](ao-2019-00896m_0009){#sch1}

The final transformations of the reaction sequence, that is, removal of the bromine atom and catalytic debenzylation, were performed as two separate steps. In particular, the products **6b**--**6d** were reduced with LiAlH~4~ to give **7b**--**7d**, which in turn were subjected to catalytic hydrogenolysis leading to the formation of the target spirocyclic pyrrolidines **1b**--**1d**. The desired products were isolated as hydrochlorides in 71--74% yields (over two steps). Therefore, all the minor improvements of the procedures allowed increasing the overall yield of the target products to 62--67%. Moreover, spirocyclic pyrrolidines **1e**, **1h**, **1i**, and **1j** bearing a seven-membered ring or cyclic ether moiety could be also obtained as hydrochlorides in 66--74% overall yields ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

###### Overall Yields of Spirocyclic Pyrrolidines **1a**--**1r** Obtained in This Work

                overall yield (%)             
  ---- -------- ------------------- ---- ---- ----
  1    **1a**                                 24
  2    **1b**   62                  56         
  3    **1c**   65                             
  4    **1d**   67                  43         
  5    **1e**   69                  43         
  6    **1f**                       22   39    
  7    **1g**   42                             
  8    **1h**   66                             
  9    **1i**   74                             
  10   **1j**   67                             
  11   **1k**                            49    
  12   **1l**                            46    
  13   **1m**                       25         
  14   **1n**                       31         
  15   **1o**                       47         
  16   **1p**   27                       43    
  17   **1r**                            31    

Unfortunately, the synthetic scheme (i.e., approach I) was not fruitful with the compounds **1f**, **1k**, and **1m** bearing the thioether moieties due to their partial oxidation at the bromination step, as well as issues with catalytic debenzylation. Compound **1g** bearing a sulfone group could be obtained in moderate overall yield (42%); in this case, the reductive debromination step was problematic (48% yield). Similar issues were observed with the products **1p** and **1r**. Unfortunately, no further improvement of the overall yields could be achieved for these compounds.

Therefore, alternative synthetic schemes to avoid the problematic steps mentioned above had been considered (approach II, [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). For starters, we decided to use the Cbz protective group instead of the benzyl moiety. To this end, the Sakurai reaction of ketones **2** with readily available allyltrimethylsilane and *O*-benzyl carbamate^[@ref21]^ was selected. The HBF~4~·Et~2~O catalyst, which was used in the previous publication referenced above was replaced with more common BF~3~·Et~2~O, which is also more convenient for the scale-up. This replacement, as well decreasing the reaction temperature from rt to 0 °C and changing the solvent from CH~3~CN to CH~2~Cl~2~, resulted in an increase of the yield of the intermediate **8d** from 56 to 74% (as compared to the literature procedure). Moreover, this yield was maintained when the reaction was performed at up to a 100 g scale.

![Synthesis of Spirocyclic Pyrrolidines (Approach II)](ao-2019-00896m_0008){#sch2}

Further, part of the synthetic sequence was also altered significantly. In particular, cyclization of mesylates **10** was considered as the key step for the construction of the pyrrolidine ring. The compounds **10** were obtained via hydroboration--oxidation of the product **8**, followed by mesylation of the resulting alcohol **9**. In this part of the synthetic scheme, the hydroboration--oxidation step seemed to be the most problematic for the scale-up. Nevertheless, 71--83% yields could still be achieved. It should be noted that the use of freshly prepared borane (by reaction of NaBH~4~ and I~2~) was critical at this step. All the experiments with common commercial sources of BH~3~ led to the diminished yields of alcohol **9**.

The final step of the synthetic sequence (approach II) included Pd-catalyzed hydrogenolysis of the Cbz moiety. The products **1b**, **1d**, **1e**, and **1o** (whose synthesis was not tested via approach I) were obtained as hydrochlorides in 43--56% overall yields ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

All our attempts to adjust the aforementioned reaction sequence for the preparation of the compounds **1f** and **1m** bearing the thioether moiety were not fruitful. The presence of the sulfur (II) atom made the catalytic hydrogenolysis ([General Procedure xi](#sec4.10){ref-type="other"}) impossible. Other methods of the Cbz group cleavage (i.e., refluxing with concd aq HBr or Me~3~SiI) led to partial decomposition of the thioether ring so that the products were obtained in low yield and with modest purity. Nevertheless, approach II was efficient for the preparation of the Cbz-protected derivative **11m**, which could be easily converted to SO~2~-containg product **11n** via oxidation with the RuCl~3~--NaIO~4~ system. Deprotection of **11n** by catalytic hydrogenolysis ([General Procedure xi](#sec4.10){ref-type="other"}) led to the target product **1n** in 31% overall yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Synthesis of Spirocyclic Pyrrolidine **1n** (Approach II)](ao-2019-00896m_0007){#sch3}

To obtain the target products **1f** and **1m** using approach II, the Cbz protective group had to be replaced with carboxyethyl ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). To achieve this, ethyl carbamate was used in the Sakurai reaction, which led to the corresponding products **12f** and **12m**. Further transformations of **12f** and **12m** followed [General Procedures viii](#sec4.7){ref-type="other"}--[x](#sec4.9){ref-type="other"} described above for the Cbz counterparts and led to the spirocyclic compounds **15f** and **15m**. Finally, the target products **1f** and **1m** were obtained as hydrochlorides in 22 and 25% overall yield, respectively, by reaction of **15f** and **15m** with hydrazine hydrate and KOH in ethylene glycol at 155 °C.

![Synthesis of Sulfur-Containing Spirocyclic Pyrrolidines **1f** and **1m** (Approach II)](ao-2019-00896m_0006){#sch4}

Despite many derivatives of general formula **1** could be obtained using approach II, for some of them (e.g., sulfur-containing compounds), the overall yields remained far from being excellent. Therefore, one more synthetic sequence was elaborated (approach III), which started with preparation of compounds **16** by the Petasis reaction of ketones **2**, pinacol allylboronate, and NH~3~ in methanol ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). The main advantage of this method is formation of product **16** as a free amine so that any protective group can be installed at the nitrogen atom in further transformations. In particular, Boc protection was used to obtain the sulfur-containing spirocyclic pyrrolidines **1f**, **1k**, and **1l** via the typical reaction sequence discussed above ([General Procedures viii](#sec4.7){ref-type="other"}--[x](#sec4.9){ref-type="other"}); the target products were obtained as hydrochlorides in 39--49% overall yield. It should be outlined that approach III appeared to be more fruitful as compared to approach II in terms of the overall yield (39 vs 22%, respectively, in the case of **1f**; [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

![Synthesis of Sulfur-Containing Spiropyrrolidines **1f**, **1k**, and **1l** (Approach III)](ao-2019-00896m_0005){#sch5}

Another variation of this approach relied on the use of trifluoroacetyl as the protecting group. In this case, the method could be extended to Boc-protected piperidones **2p** and **2r** ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). The corresponding products of the Petasis reaction **16p** and **16r** were trifluoroacetylated, and the resulting orthogonally protected diamines **17p** and **17r** were introduced into the typical reaction sequence discussed above ([General Procedures viii](#sec4.7){ref-type="other"}--[x](#sec4.9){ref-type="other"}). Removal of the trifluoroacetyl group in the products **20p** and **20r** thus obtained accomplished the synthesis of *N*-Boc-monoprotected diamines **1p** and **1r** (43 and 31% overall yield, respectively).

![Synthesis of *N*-Boc-Monoprotected Diamines **1p** and **1r** (Approach III)](ao-2019-00896m_0004){#sch6}

In our opinion, approach III can be considered as the most convenient of the methods discussed herein for "challenging" spirocyclic pyrrolidines bearing an additional functional group. Nevertheless, none of the approaches I--III can be applied for those synthetic targets where the corresponding cyclic ketone **2** is not accessible or even unstable. This was the case with 4-azaspiro\[2.4\]heptane (**1a**) bearing the cyclopropyl moiety. We assumed that an alternative approach to the key intermediate **17a**, which would not require formation of unstable cyclopropanone (**2a**), should be elaborated to accomplish synthesis of **1a** ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). To this end, it turned out that *tert*-butyl cyclopropylcarboxylate (**21a**) can be an appropriate starting compound. Compound **17a** was obtained from **21a** in 50% yield over three steps including allylation,^[@ref22]^ acidic hydrolysis, and modified Curtius rearrangement. Further transformations of **17a** followed the typical synthetic sequence used in this work ([General Procedures viii](#sec4.7){ref-type="other"}--[x](#sec4.9){ref-type="other"} and [xiv](#sec4.13){ref-type="other"}) and led to the target compound **1a** as hydrochloride (24% overall yield).

![Synthesis of 4-Azaspiro\[2.4\]heptane (**1a**) (Approach IV)](ao-2019-00896m_0003){#sch7}

It should be noted that several spirocyclic pyrrolidines obtained in this work (compounds **1i**--**1n** and **1r**) contained an asymmetric carbon atom. We have demonstrated that they can be obtained as pure enantiomers via preparative chiral stationary phase chromatography for the case of the compound **1n**. Separation was achieved for the Cbz derivative **11n** using a Chiralcel OD-H column (hexane--*i*-PrOH--MeOH (60:20:20) as eluent). Both enantiomers (*R*)-**1n** and (*S*)-**1n** were obtained after deprotection of (*R*)-**11n** and (*S*)-**11n** ([General Procedure xi](#sec4.10){ref-type="other"}). Absolute configuration of these compounds was determined by X-ray diffraction studies for the hydrochloride (*R*)-**1n**·HCl ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}).

![Molecular structure of (*R*)-**1n**·HCl.](ao-2019-00896m_0011){#fig4}

Conclusions {#sec3}
===========

It is a common situation in organic chemistry and drug discovery that some compounds, although appearing to be described in the literature via a number of published synthetic methodologies, become challenging targets when their preparation for industrial use or even late-stage R&D is necessary. It often happens when multigram scale-up (to ∼100 g, in some cases -- even ∼10 g) and extension of the scope toward "inconvenient" functionalized substrates are required -- a problem highlighted by Churcher and co-workers in their recent perspective.^[@ref23]^ As part of our ongoing research on medicinally relevant building blocks, we faced such a problem in the case of spirocyclic pyrrolidines. This resulted in development of four synthetic approaches (one being an optimization of the literature method), which were used for the preparation of 17 building blocks at the multigram scale. It was found that approach I (based on the method of Jenkins et al.^[@ref18]^) was optimal for the simplest non-functionalized substrates, which were obtained from common cyclic ketones in 62--74% overall yield. Approach II, which was based on the Sakurai reaction, partially solved the problems with sulfur-containing substrates; however, the overall yields of the target products diminished (43--56% for the simplest representatives and 22--31% for the organosulfur derivatives). Approach III, which relied on the Petasis reaction, appeared to be the most general since it allowed for the largest variation of the protective groups for the key intermediates. In particular, it was efficient in the case of either sulfur-containing products (39--49% overall yield) or monoprotected spirocyclic diamines (31--43% overall yield). Finally, approach IV was developed for those substrates where the corresponding cyclic ketone is not available. Its utility was demonstrated for the smallest representative of the series studied---4-azaspiro\[2.4\]heptane, which was obtained in 24% total yield. The developed synthetic schemes included 5--7 steps, commenced from readily available starting materials, were scalable up to 100 g, and led to biologically relevant spirocyclic pyrrolidines---advanced building blocks for drug discovery, which can be now considered as readily available to the chemical community.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

The solvents were purified according to the standard procedures. All starting materials were purchased from commercial sources. Melting points were measured on an automated melting point system. Column chromatography was performed using a silica gel (230--400 mesh) as the stationary phase. ^1^H, and ^13^C, and ^19^F NMR spectra were recorded at 499.9 or 400.4, 124.9 or 100.7, and 376 MHz, respectively. Chemical shifts are reported in ppm downfield from TMS as an internal standard. Elemental analyses were performed at the Laboratory of Organic Analysis, Department of Chemistry, National Taras Shevchenko University of Kyiv, and their results were found to be in good agreement (±0.4%) with the calculated values. Mass spectra were recorded on an 1100 LCMSD SL instrument (chemical ionization (APCI), electrospray ionization (ESI)) and GCMS instrument (electron impact ionization (EI)). Chiral chromatography was performed on a Chiralcel OD-H (250 20 mm 5 μm) column, mobile phase: hexane--IPA--MeOH 60/20/20, flow rate: 25 mL/min, column temperature: 24 °C, and wavelength: 205 nm. The optical rotation was determined using an MCP 300 modular circular polarimeter.

X-Ray diffraction studies were performed on CCDC-1896555, which contains the supplementary crystallographic data for this paper (compound (*R*)-**1n**·HCl). These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via [www.ccdc.cam.ac.uk/data_request/cif](www.ccdc.cam.ac.uk/data_request/cif).

General Procedures i and ii {#sec4.2}
---------------------------

Ketone **2** (1.0 mol) was dissolved in dry toluene (1500 mL), and benzylamine (1.0 mol, 105 mL) was added. The reaction mixture was refluxed for 1 h with a Dean--Stark trap and an effective condenser until complete water separation (18 mL). Toluene was evaporated, and the obtained product was used in the next step without further purification.

The obtained crude compound **3** (1.0 mol) was dissolved in THF (2000 mL) and cooled to −20 °C. A solution of allylmagnesium chloride in THF (2 M, 500 mL) was added dropwise to the obtained solution for 30 min keeping the reaction mixture temperature below −15 °C. The reaction mixture was allowed to warm to rt and left overnight. A saturated solution of NH~4~Cl (∼500 mL) was added for complete precipitation of magnesium salts. The organic layer was separated, and the THF layer was dried under Na~2~SO~4~ and was evaporated under reduced pressure. The residue was distilled in vacuum (0.2 mmHg).

### 1-Allyl-*N*-benzylcyclobutanamine (**4b**) {#sec4.2.1}

Yield = 185.2 g, 92%, colorless liquid (bp = 74--75 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.35--7.25 (m, 4H), 7.23--7.17 (m, 1H), 5.86 (m, 1H), 5.14--5.00 (m, 2H), 3.59 (s, 2H), 2.33 (d, *J* = 7.1 Hz, 2H), 1.90 (td, *J* = 9.4, 2.4 Hz, 2H), 1.79 (m, 2H), 1.67 (m, 2H); the proton of the NH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 142.2, 135.9, 128.5, 128.4, 126.8, 117.3, 59.4, 46.4, 41.4, 32.2, 13.5. LCMS, positive mode, *m*/*z*: 202.2 \[M + H\]^+^. Anal calcd for C~14~H~19~N: C, 83.53; H, 9.51; N, 6.96. Found: C, 83.40; H, 9.84; N, 6.87.

### 1-Allyl-*N*-benzylcyclopentanamine (**4c**) {#sec4.2.2}

Yield = 198.1 g, 92%, colorless liquid (bp = 88--89 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.34--7.25 (m, 4H), 7.19 (t, *J* = 6.8 Hz, 1H), 5.89 (m, 1H), 5.16--5.00 (m, 2H), 3.62 (s, 2H), 2.28 (d, *J* = 7.2 Hz, 2H), 1.68 (m, 2H), 1.62--1.48 (m, 4H), 1.43 (dd, *J* = 12.3, 5.8 Hz, 2H), the proton of the NH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 142.4, 136.4, 128.5, 126.8, 117.3, 64.7, 46.8, 42.0, 37.1, 24.2. LCMS, positive mode, *m*/*z*: 216.2 \[M + H\]^+^. Anal calcd for C~15~H~21~N: C, 83.67; H, 9.83; N, 6.50. Found: C, 83.55; H, 9.78; N, 6.77.

### 1-Allyl-*N*-benzylcyclohexanamine (**4d**) {#sec4.2.3}

Yield = 220.2 g, 96%, colorless liquid (bp = 106--107 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.34 (d, *J* = 7.6 Hz, 2H), 7.29 (t, *J* = 7.4 Hz, 2H), 7.20 (t, *J* = 7.2 Hz, 1H), 5.88 (m, 1H), 5.13--4.99 (m, 2H), 3.59 (d, *J* = 5.9 Hz, 2H), 2.19 (d, *J* = 7.3 Hz, 2H), 1.64--1.41 (m, 5H), 1.31 (m, 5H); the proton of the NH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 142.5, 135.5, 128.5, 126.8, 117.5, 53.9, 45.1, 42.3, 35.4, 26.3, 21.7. LCMS, positive mode, *m*/*z*: 230 \[M + H\]^+^. Anal calcd for C~16~H~23~N: C, 83.79; H, 10.11; N, 6.11. Found: C, 83.58; H, 10.02; N, 5.92.

### 4-Allyl-*N*-benzyltetrahydro-2H-pyran-4-amine (**4e**) {#sec4.2.4}

yield = 208.2 g, 90%, colorless liquid (bp = 117--118 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.37 (d, *J* = 7.3 Hz, 2H), 7.30 (t, *J* = 7.5 Hz, 2H), 7.21 (t, *J* = 7.2 Hz, 1H), 5.88 (m, 1H), 5.18--5.04 (m, 2H), 3.72 (ddd, *J* = 12.3, 9.3, 3.6 Hz, 2H), 3.61 (s, 2H), 3.51 (dt, *J* = 11.3, 4.2 Hz, 2H), 2.25 (d, *J* = 7.3 Hz, 2H), 1.60--1.39 (m, 4H); the proton of the NH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 142.3, 134.8, 128.53, 128.50, 126.9, 118.1, 63.2, 52.0, 45.1, 42.5, 35.7. LCMS, positive mode, *m*/*z*: 232.2 \[M + H\]^+^. Anal calcd for C~15~H~21~NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 77.81; H, 9.3; N, 5.92.

### 4-Allyl-4-(benzylamino)tetrahydro-2*H*-thiopyran 1,1-dioxide (**4g**) {#sec4.2.5}

Yield = 134.1 g, 96%, colorless liquid (compound was purified by flash column chromatography). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.37 (d, *J* = 7.6 Hz, 2H), 7.32 (t, *J* = 7.5 Hz, 2H), 7.23 (t, *J* = 7.2 Hz, 1H), 5.85 (m, 1H), 5.21--5.07 (m, 2H), 3.61 (s, 2H), 3.26 (td, *J* = 13.5, 3.4 Hz, 2H), 2.82 (d, *J* = 11.6 Hz, 2H), 2.28 (d, *J* = 7.4 Hz, 2H), 2.12--1.97 (m, 2H), 1.91--1.77 (m, 2H); the proton of the NH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 141.7, 134.4, 128.62, 128.55, 127.1, 118.8, 52.1, 47.0, 45.1, 42.3, 32.6. LCMS, positive mode, *m*/*z*: 280 \[M + H\]^+^. Anal calcd for C~15~H~21~NO~2~S: C, 64.48; H, 7.58; N, 5.01; S, 11.47. Found: C, 64.84; H, 7.59; N, 4.61; S, 11.66.

### 1-Allyl-*N*-benzylcycloheptanamine (**4h**) {#sec4.2.6}

Yield = 231.2 g, 95%, colorless liquid (bp = 120--121 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.37--7.26 (m, 4H), 7.21 (t, *J* = 7.2 Hz, 1H), 5.87 (m, 1H), 5.16--5.01 (m, 2H), 3.63 (s, 2H), 2.21 (d, *J* = 7.3 Hz, 2H), 1.54 (m, 10H), 1.37 (t, *J* = 10.2 Hz, 2H); the proton of the NH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 141.4, 135.6, 128.7, 128.5, 127.1, 117.9, 58.6, 45.5, 43.3, 38.2, 30.1, 22.3. LCMS, positive mode, *m*/*z*: 244 \[M + H\]^+^. Anal calcd for C~17~H~25~N: C, 83.89; H, 10.35; N, 5.75. Found: C, 83.49; H, 10.42; N, 5.80.

### 3-Allyl-*N*-benzyltetrahydrofuran-3-amine (**4i**) {#sec4.2.7}

Yield = 206.4 g, 95%, dark yellow liquid (compound was obtained with 85% purity and used in the next step without additional purification). LCMS, positive mode, *m*/*z*: 218.2 \[M + H\]^+^.

### 4-Allyl-*N*-benzyltetrahydro-2*H*-pyran-4-amine (**4j**) {#sec4.2.8}

Yield = 208.2 g, 90%, colorless liquid (bp = 114--115 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.38--7.25 (m, 4H), 7.20 (t, *J* = 7.2 Hz, 1H), 5.88 (m, 1H), 5.12--5.00 (m, 2H), 3.62 (s, 2H), 3.57--3.41 (m, 4H), 2.29--2.13 (m, 2H), 1.74--1.42 (m, 4H); the proton of the NH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 142.2, 135.0, 128.53, 128.50, 126.9, 117.5, 74.8, 67.9, 52.9, 45.1, 38.6, 31.9, 22.3. LCMS, positive mode, *m*/*z*: 232.2 \[M + H\]^+^. Anal calcd for C~15~H~21~NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 78.11; H, 8.82; N, 5.93.

General Procedures iii and iv {#sec4.3}
-----------------------------

Compound **4** (0.95 mol) was dissolved in CH~2~Cl~2~ (2000 mL) and was added to the 48% aqueous solution of HBr (0.95 mol, 240 mL). Then, Br~2~ (1 mol, 500 mL) was slowly added dropwise to the obtained mixture for 1 h keeping the temperature below 25 °C. The resulting mixture was cooled to rt and left for 1 h resulting in formation of **5**.

Triethylamine (1.5 mol, 110 mL) was added dropwise at rt to the obtained solution of **5** in [General Procedure iii](#sec4.3){ref-type="other"} for 25--30 min keeping the temperature below 25 °C (**Caution**: exothermic process). The resulting solution was left at rt for 1 h. Distilled water (500 mL) was added to the solution to extract all water-soluble impurities and triethylammonium bromide. The organic layer was separated and dried over Na~2~SO~4~, and the solvent was evaporated under reduced pressure. The obtained product **6** with a purity of approximately 90% was used in the next step without further purification. The analytical samples were additionally purified by flash column chromatography.

### 5-Benzyl-7-bromo-5-azaspiro\[3.4\]octane (**6b**) {#sec4.3.1}

Yield = 266.2 g, 100%, brown oil. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.38--7.27 (m, 4H), 7.23 (m, 1H), 4.50 (m, 1H), 3.87--3.60 (m, 2H), 3.08--2.96 (m, 1H), 2.82 (dd, *J* = 11.2, 4.3 Hz, 1H), 2.69 (dd, *J* = 13.7, 7.9 Hz, 1H), 2.44--2.21 (m, 3H), 1.92 (m, 1H), 1.66 (m, 3H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 140.2, 128.6, 128.5, 127.2, 66.6, 61.4, 52.3, 50.0, 45.2, 30.6, 29.9, 13.8. LCMS, positive mode, *m*/*z*: 280.0 \[M + H\]^+^. Anal calcd for C~14~H~18~BrN: C, 60.01; H, 6.48; N, 5.00; Br, 28.52. Found: C, 60.34; H, 6.77; N, 4.86; Br, 28.22.

### 1-Benzyl-3-bromo-1-azaspiro\[4.4\]nonane (**6c**) {#sec4.3.2}

Yield = 279.5 g, 100%, brown oil. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.31 (m, 4H), 7.22 (m, 1H), 4.51 (m, 1H), 3.72--3.42 (m, 2H), 3.09--2.79 (m, 2H), 2.48--2.42 (m, 1H), 2.15 (dd, *J* = 13.7, 5.1 Hz, 1H), 1.88--1.77 (m, 1H), 1.76--1.46 (m, 6H), 1.36 (dd, *J* = 12.4, 7.0 Hz, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 140.4, 128.6, 128.5, 127.2, 72.5, 61.8, 51.8, 51.5, 45.5, 33.5, 31.9, 24.1, 23.9. LCMS, positive mode, *m*/*z*: 294 \[M + H\]^+^. Anal calcd for C~15~H~20~BrN: C, 61.23; H, 6.85; N, 4.76; Br, 27.16. Found: C, 60.86; H, 7.09; N, 5.11; Br, 27.37.

### 1-Benzyl-3-bromo-1-azaspiro\[4.5\]decane (**6d**) {#sec4.3.3}

Yield = 293.0 g, 100%, brown oil. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.31 (m, 4H), 7.22 (m, 1H), 4.51 (m, 1H), 3.77--3.49 (dd, *J* = 71.3, 11.6 Hz, 2H), 2.97 (ddd, *J* = 71.3, 12.8, 5.1 Hz, 2H), 2.49 (m, 1H), 2.10 (dd, *J* = 12.8, 5.1 Hz, 1H), 1.78--1.49 (m, 5H), 1.46--1.35 (m, 2H), 1.29 (m, 2H), 1.10 (m, 1H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 140.3, 128.8, 128.4, 127.4, 59.7, 51.4, 45.9, 33.6, 32.3, 25.7, 24.1, 23.7. LCMS, positive mode, *m*/*z*: 308 \[M + H\]^+^. Anal calcd for C~16~H~22~BrN: C, 62.34; H, 7.19; N, 4.54; Br, 25.92. Found: C, 62.12; H, 7.30; N, 4.94; Br, 25.75.

### 1-Benzyl-3-bromo-8-oxa-1-azaspiro\[4.5\]decane (**6e**) {#sec4.3.4}

Yield = 294.7 g, 100%, brown oil. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.31 (m, 4H), 7.26--7.18 (m, 1H), 4.53 (q, *J* = 5.9, 5.2 Hz, 1H), 3.87 (td, *J* = 12.7, 4.6 Hz, 2H), 3.74 (d, *J* = 13.7 Hz, 1H), 3.56 (d, *J* = 13.5 Hz, 1H), 3.43--3.34 (m, 2H), 3.07 (t, *J* = 8.6 Hz, 1H), 2.89 (m, 1H), 2.63 (dd, *J* = 14.4, 8.1 Hz, 1H), 2.21 (dd, *J* = 14.4, 4.8 Hz, 1H), 1.87 (q, *J* = 10.9 Hz, 1H), 1.72 (q, *J* = 10.0, 8.2 Hz, 1H), 1.50 (d, *J* = 12.9 Hz, 1H), 1.30 (d, *J* = 12.9 Hz, 1H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 140.6, 128.6, 128.5, 127.1, 65.7, 65.4, 61.6, 60.0, 51.0, 46.3, 45.9, 34.7, 32.8. LCMS, positive mode, *m*/*z*: 310 \[M + H\]^+^. Anal calcd for C~15~H~20~BrNO: C, 58.07; H, 6.50; N, 4.51; Br, 25.76. Found: C, 58.00; H, 6.33; N, 4.15; Br, 25.37.

### 1-Benzyl-3-bromo-8-thia-1-azaspiro\[4.5\]decane 8,8-dioxide (**6g**) {#sec4.3.5}

Yield = 170.2 g, 100%, dark brown oil. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.39--7.18 (m, 5H), 4.56 (tt, *J* = 8.1, 4.6 Hz, 1H), 3.75 (d, *J* = 13.5 Hz, 1H), 3.54 (d, *J* = 13.5 Hz, 1H), 3.37--2.03 (m, 10H), 2.03--1.73 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 140.0, 128.7, 128.5, 127.3, 61.7, 60.2, 50.9, 49.0, 48.6, 45.6, 45.3, 32.4, 29.6. EIMS, 70 eV, *m*/*z* (rel. int.): 359 \[M + H\]^+^ (2); 267 (44); 266 (12); 265 (44); 132 (11); 131 (100); 91 (88); 65 (19); 41 (19); 39 (13). Anal calcd for C~15~H~20~BrNO~2~S: C, 50.28; H, 5.63; N, 3.91; S, 8.95; Br, 22.30. Found: C, 50.46; H, 5.81; N, 4.22; S, 9.31; Br, 22.03.

### 1-Benzyl-3-bromo-1-azaspiro\[4.6\]undecane (**6h**) {#sec4.3.6}

Yield = 306.2 g, 100%, brown oil. ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.55--7.17 (m, 5H), 4.48 (s, 1H), 3.62 (dd, *J* = 73.2, 13.4 Hz, 2H), 3.06--2.75 (m, 2H), 2.10 (d, *J* = 13.2 Hz, 1H), 1.85 (d, *J* = 11.9 Hz, 1H), 1.79--1.28 (m, 12H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 143.3, 131.6, 130.0, 129.3, 59.0, 51.4, 46.7, 36.8, 29.0, 28.7, 23.6, 22.4; LCMS, positive mode, *m*/*z*: 323 \[M + H\]^+^. Anal calcd for C~17~H~24~BrN: C, 63.36; H, 7.51; N, 4.35; Br, 24.79. Found: C, 63.18; H, 7.32; N, 4.53; Br, 24.51.

### 1-Benzyl-3-bromo-7-oxa-1-azaspiro\[4.4\]nonane (**6i**) {#sec4.3.7}

Yield = 281.4 g, 100%, dark brown oil (compound was obtained with 85% purity and used in the next step without additional purification). LCMS, positive mode, *m*/*z*: 296.2 \[M + H\]^+^.

### 1-Benzyl-3-bromo-7-oxa-1-azaspiro\[4.5\]decane (**6j**) {#sec4.3.8}

Yield = 294.7 g, 100%, dark brown oil (compound was obtained with 85% purity and used in the next step without additional purification). LCMS, positive mode, *m*/*z*: 310.2 \[M + H\]^+^.

General Procedure v {#sec4.4}
-------------------

The crude compound **6** (0.95 mol) was dissolved in THF (1000 mL), and the obtained solution was added dropwise at rt to a solution of LiAlH~4~ (2 mol, 76 g) in THF (2000 mL) under stirring for 2 h keeping the reaction temperature at 0 °C. The reaction mixture was allowed to warm to rt and stirred for 72 h. A mixture of water with THF (1:4, ∼500 mL) was carefully added to the reaction mixture until the excess of LiAlH~4~ was completely neutralized. The organic layer was separated and dried over Na~2~SO~4~, and the solvent was evaporated under reduced pressure. The residue was distilled in vacuum (0.2 mmHg).

### 5-Benzyl-5-azaspiro\[3.4\]octane (**7b**) {#sec4.4.1}

Yield = 141.5 g, 74%, colorless liquid (bp = 83--84 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.29 (d, *J* = 4.4 Hz, 4H), 7.20 (h, *J* = 4.1 Hz, 1H), 3.65 (s, 2H), 2.43 (t, *J* = 7.3 Hz, 2H), 2.32--2.18 (m, 2H), 1.97--1.86 (m, 2H), 1.64 (m, 6H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 141.0, 128.6, 128.5, 126.9, 66.4, 53.4, 51.1, 38.4, 29.6, 20.4, 13.9. LCMS, positive mode, *m*/*z*: 202.2 \[M + H\]^+^. Anal calcd for C~14~H~19~N: C, 83.53; H, 9.51; N, 6.96. Found: C, 83.35; H, 9.79; N, 7.28.

### 1-Benzyl-1-azaspiro\[4.4\]nonane (**7c**) {#sec4.4.2}

Yield = 147.3 g, 72%, colorless liquid (bp = 97--98 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.28 (d, *J* = 4.3 Hz, 4H), 7.20 (h, *J* = 4.2 Hz, 1H), 3.51 (s, 2H), 2.48--2.43 (m, 2H) 1.80--1.46 (m, 10H), 1.36 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 141.2, 128.6, 128.5, 126.9, 72.1, 52.9, 51.6, 39.8, 32.0, 24.3, 20.9. LCMS, positive mode, *m*/*z*: 216.2 \[M + H\]^+^. Anal calcd for C~15~H~21~N: C, 83.67; H, 9.83; N, 6.50. Found: C, 83.99; H, 9.64; N, 6.21.

### 1-Benzyl-1-azaspiro\[4.5\]decane (**7d**) {#sec4.4.3}

Yield = 155.0 g, 71%, colorless liquid (bp = 110--111 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.37--7.14 (m, 5H), 3.56 (s, 2H), 2.54 (s, 2H), 1.64 (m, 7H), 1.40 (m, 6H), 1.10 (t, *J* = 13.1 Hz, 1H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 141.6\*, 140.8, 128.6\*, 128.5, 128.4, 127.0\*, 126.8, 63.7\*, 62.9, 60.2, 52.2, 51.0\*, 50.6, 46.7\*, 46.2, 34.5, 34.1\*, 32.6, 32.3\*, 26.3, 25.9\*, 24.4, 24.2\*, 24.0\*, 21.1 (\*due to hindered rotation). LCMS, positive mode, *m*/*z*: 230.2 \[M + H\]^+^. Anal calcd for C~16~H~23~N: C, 83.79; H, 10.11; N, 6.11. Found: C, 83.73; H, 10.06; N, 6.27.

### 1-Benzyl-8-oxa-1-azaspiro\[4.5\]decane (**7e**) {#sec4.4.4}

Yield = 171.4 g, 78%, colorless liquid (bp = 127--128 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.28 (d, *J* = 4.4 Hz, 4H), 7.23--7.17 (m, 1H), 3.86 (dd, *J* = 11.4, 4.9 Hz, 2H), 3.57 (s, 2H), 3.38 (td, *J* = 12.1, 2.0 Hz, 2H), 2.54 (t, *J* = 7.0 Hz, 2H), 1.81--1.70 (m, 4H), 1.66 (m, 2H), 1.25 (dd, *J* = 12.7, 2.0 Hz, 2H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 141.3, 128.6, 128.5, 126.9, 65.9, 60.8, 52.1, 50.4, 34.0, 33.2, 21.0. LCMS, positive mode, *m*/*z*: 232.2 \[M + H\]^+^. Anal calcd for C~15~H~21~NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 78.15; H, 9.50; N, 6.36.

### 1-Benzyl-8-thia-1-azaspiro\[4.5\]decane 8,8-dioxide (**7g**) {#sec4.4.5}

Yield = 64.4 g, 48%, colorless liquid (compound was purified by flash column chromatography). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.29 (m, 4H), 7.21 (m, 1H), 3.56 (s, 2H), 3.22 (td, *J* = 13.9, 3.4 Hz, 2H), 3.07 (d, *J* = 11.8 Hz, 2H), 2.55 (t, *J* = 7.1 Hz, 2H), 2.14 (t, *J* = 12.7 Hz, 2H), 1.87 (m, 2H), 1.80--1.61 (m, 4H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 140.7, 128.6, 127.1, 61.2, 52.0, 50.6, 49.2, 33.3, 30.1, 20.7. LCMS, positive mode, *m*/*z*: 280 \[M + H\]^+^. Anal calcd for C~15~H~21~NO~2~S: C, 64.48; H, 7.58; N, 5.01; S, 11.47. Found: C, 64.69; H, 7.96; N, 4.86; S, 11.20.

### 1-Benzyl-1-azaspiro\[4.6\]undecane (**7h**) {#sec4.4.6}

Yield = 166.5 g, 72%, colorless liquid (bp = 121--122 °C, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.28 (d, *J* = 4.4 Hz, 4H), 7.19 (p, *J* = 4.4 Hz, 1H), 3.58 (s, 2H), 2.46 (d, *J* = 7.3 Hz, 2H), 1.79--1.69 (m, 2H), 1.63 (m, 6H), 1.51 (m, 6H), 1.41 (m, 2H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 141.4, 128.6, 128.5, 126.9, 65.8, 52.6, 50.7, 37.8, 35.6, 29.3, 24.0, 20.9. LCMS, positive mode, *m*/*z*: 244.2 \[M + H\]^+^. Anal calcd for C~17~H~25~N: C, 83.89; H, 10.35; N, 5.75. Found: C, 83.72; H, 10.23; N, 5.38.

### 1-Benzyl-7-oxa-1-azaspiro\[4.4\]nonane (**7i**) {#sec4.4.7}

Yield = 169.3 g, 82%, colorless liquid (bp = 109--110, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.28 (d, *J* = 4.4 Hz, 4H), 7.20 (m, 1H), 3.90 (td, *J* = 8.6, 4.3 Hz, 1H), 3.79 (d, *J* = 9.0 Hz, 1H), 3.73--3.61 (m, 2H), 3.51 (d, *J* = 13.4 Hz, 1H), 3.39 (d, *J* = 9.0 Hz, 1H), 2.60--2.51 (m, 1H), 2.40 (td, *J* = 8.9, 6.3 Hz, 1H), 2.09 (dt, *J* = 12.6, 8.5 Hz, 1H), 1.82 (ddd, *J* = 8.3, 6.8, 3.0 Hz, 2H), 1.73--1.60 (m, 3H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 140.3, 128.4, 128.2, 126.7, 73.9, 71.6, 68.2, 53.4, 51.5, 37.6, 32.7, 21.2; LCMS, positive mode, *m*/*z*: 218.2 \[M + H\]^+^. Anal calcd for C~14~H~19~NO: C, 77.38; H, 8.81; N, 6.45. Found: C, 77.00; H, 8.77; N, 6.83.

### 1-Benzyl-7-oxa-1-azaspiro\[4.5\]decane (**7j**) {#sec4.4.8}

Yield = 173.6 g, 79%, colorless liquid (bp = 126--127, 0.2 mmHg). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 7.31--7.24 (m, 4H), 7.20 (td, *J* = 6.0, 2.6 Hz, 1H), 3.74 (m, 1H), 3.69 (s, 2H), 3.38 (dd, *J* = 10.7, 2.3 Hz, 1H), 3.27 (d, *J* = 10.7 Hz, 1H), 3.20 (m, 1H), 2.63--2.51 (m, 2H), 1.93 (dd, *J* = 12.1, 4.5 Hz, 1H), 1.74 (m, 1H), 1.69--1.49 (m, 6H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 141.4, 128.5, 128.4, 126.9, 72.7, 67.6, 60.6, 52.8, 51.4, 35.0, 31.0, 24.7, 21.6. LCMS, positive mode, *m*/*z*: 232.2 \[M + H\]^+^. Anal calcd for C~15~H~21~NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 78.09; H, 8.94; N, 6.14.

General Procedure vi {#sec4.5}
--------------------

Wet Pd/C (10%, 15 g) was added to the solution of **7** (0.68 mol) in 1500 mL of MeOH in an autoclave. The mixture was heated at 50 °C in an atmosphere of H~2~ (20 atm) for 6 h. Then, the catalyst was filtered off and washed with MeOH (2 × 200 mL), and the solution obtained was purified by flash column chromatography (SiO~2~). The saturated HCl/MeOH solution (500 mL) was added to the obtained solution. The solvent was removed in vacuo. The desired product as HCl salt was dried in vacuo.

### 5-Azaspiro\[3.4\]octane hydrochloride (**1b**·HCl) {#sec4.5.1}

Yield = 91.4 g, 91%, white solid (mp = 131--133 °C, dec.). ^1^H NMR (400 MHz, chloroform-*d*) δ 9.77 (br s, 2H), 3.25 (dt, *J* = 12.4, 6.0 Hz, 2H), 2.73 (dt, *J* = 11.0, 8.7 Hz, 2H), 2.11--1.99 (m, 5H), 1.93 (p, *J* = 7.0 Hz, 2H), 1.88--1.74 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 65.9, 43.1, 35.4, 31.2, 21.9, 14.9. LCMS, positive mode, *m*/*z*: 112.2 \[M--Cl\]^+^. Anal calcd for C~7~H~14~ClN: C, 56.94; H, 9.56; N, 9.49; Cl, 24.01. Found: C, 57.30; H, 9.87; N, 9.18; Cl, 24.36.

### 1-Azaspiro\[4.4\]nonane hydrochloride (**1c**·HCl) {#sec4.5.2}

Yield = 107.7 g, 98%, white solid (mp = 103--105 °C, dec.). ^1^H NMR (400 MHz, chloroform-*d*) δ 9.45 (br s, 2H), 3.31 (t, *J* = 7.5 Hz, 2H), 2.21 (m, 2H), 2.05--1.93 (m, 2H), 1.89 (t, *J* = 6.6 Hz, 4H), 1.68 (m, 4H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 74.0, 43.5, 36.3, 36.0, 24.2, 22.8. LCMS, positive mode, *m*/*z*: 126.2 \[M--Cl + H\]^+^. Anal calcd for C~8~H~16~ClN: C, 59.43; H, 9.98; N, 8.66; Cl, 21.93. Found: C, 59.20; H, 10.27; N, 8.30; Cl, 22.31.

### 1-Azaspiro\[4.5\]decane hydrochloride (**1d**·HCl) {#sec4.5.3}

Yield = 93.0 g, 98%, white solid (mp = 113--115 °C, dec). ^1^H NMR (400 MHz, chloroform-*d*) δ 9.36 (br s, 2H), 3.33 (quint, *J* = 6.6 Hz, 2H), 2.01 (quint, *J* = 7.4 Hz, 2H), 1.87 (dt, *J* = 14.8, 8.5 Hz, 4H), 1.81--1.69 (m, 4H), 1.53--1.30 (m, 4H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 67.6, 43.4, 34.6, 34.4, 24.8, 23.0, 22.4. LCMS, positive mode, *m*/*z*: 140.1 \[M--Cl + H\]^+^. Anal calcd for C~9~H~18~ClN: C, 61.52; H, 10.33; N, 7.97; Cl, 20.18. Found: C, 61.29; H, 10.49; N, 7.57; Cl, 19.78.

### 8-Oxa-1-azaspiro\[4.5\]decane hydrochloride (**1e**·HCl) {#sec4.5.4}

Yield = 118.4 g, 98%, white solid (mp = 181--184 °C, dec.). ^1^H NMR (400 MHz, chloroform-*d*) δ 9.62 (br s, 2H), 3.95 (m, 2H), 3.60 (m, 2H), 3.41 (t, *J* = 7.3 Hz, 2H), 2.17 (ddd, *J* = 12.6, 8.0, 3.9 Hz, 2H), 2.08 (p, *J* = 7.2 Hz, 2H), 1.97 (t, *J* = 7.2 Hz, 2H), 1.82 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 65.0, 64.6, 43.7, 35.1, 34.4, 22.4; LCMS, positive mode, *m*/*z*: 142.2 \[M--Cl + H\]^+^. Anal calcd for C~8~H~16~ClNO: C, 54.08; H, 9.08; N, 7.88; Cl, 19.95. Found: C, 53.78; H, 9.16; N, 7.49; Cl, 20.16.

### 8-Thia-1-azaspiro\[4.5\]decane 8,8-dioxide hydrochloride (**1g**·HCl) {#sec4.5.5}

Yield = 84.5 g, 92%, white solid (mp = 188--191 °C, with decomposition). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 8.98 (s, 2H), 3.25 (m, 6H), 2.33 (m, 2H), 2.26--2.15 (m, 2H), 1.98 (dd, *J* = 10.9, 5.2 Hz, 4H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 64.7, 47.6, 44.1, 33.7, 31.9, 22.3. LCMS, negative mode, *m*/*z*: 190.2 \[M--Cl + H\]^+^. Anal calcd for C~8~H~16~ClNO~2~S: C, 42.57; H, 7.14; N, 6.20; S, 14.20; Cl, 15.71. Found: C, 42.59; H, 7.28; N, 6.02; S, 14.07; Cl, 15.87.

### 1-Azaspiro\[4.6\]undecane hydrochloride (**1h**·HCl) {#sec4.5.6}

Yield = 125.2 g, 97%, white solid (mp = 127--130 °C, dec.). ^1^H NMR (400 MHz, chloroform-*d*) δ 9.33 (s, 2H), 3.32 (p, *J* = 6.6 Hz, 2H), 2.11 (dd, *J* = 14.5, 10.0 Hz, 2H), 1.99 (p, *J* = 7.4 Hz, 2H), 1.83 (q, *J* = 8.7, 8.0 Hz, 4H), 1.74 (dd, *J* = 14.9, 7.6 Hz, 2H), 1.59 (m, 2H), 1.50 (m, 2H), 1.42 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 71.3, 43.4, 37.3, 36.6, 29.2, 23.1, 22.2. LCMS, positive mode, *m*/*z*: 190 \[M\]^+^. Anal calcd for C~10~H~20~ClN: C, 63.31; H, 10.63; N, 7.38; Cl, 18.68. Found: C, 63.56; H, 10.48; N, 7.40; Cl, 18.47.

### 7-Oxa-1-azaspiro\[4.4\]nonane hydrochloride (**1i**·HCl) {#sec4.5.7}

Yield = 105.7 g, 95%, white solid (mp = 125--127 °C, dec.). ^1^H NMR (400 MHz, chloroform-*d*) δ 9.83 (s, 2H), 4.39 (d, *J* = 10.2 Hz, 1H), 4.20 (q, *J* = 8.0 Hz, 1H), 3.90 (td, *J* = 8.9, 4.9 Hz, 1H), 3.63 (d, *J* = 10.2 Hz, 1H), 3.48--3.36 (m, 2H), 2.66 (ddd, *J* = 13.1, 7.8, 4.9 Hz, 1H), 2.14--1.90 (m, 5H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 73.9, 72.9, 67.5, 44.3, 36.1, 33.4, 23.1. LCMS, positive mode, *m*/*z*: 128.4 \[M--Cl + H\]^+^. Anal calcd for C~7~H~14~ClNO: C, 51.38; H, 8.62; N, 8.56; Cl, 21.66. Found: C, 51.14; H, 8.87; N, 8.95; Cl, 22.01.

### 7-Oxa-1-azaspiro\[4.5\]decane (**1j**) {#sec4.5.8}

Yield = 91.2 g, 95%, white vitreous solid. ^1^H NMR (400 MHz, chloroform-*d*) δ 3.63--3.49 (m, 2H), 3.32--3.22 (m, 2H), 2.95 (dt, *J* = 10.2, 6.3 Hz, 1H), 2.86 (dt, *J* = 10.2, 7.0 Hz, 1H), 1.84 (s, 1H), 1.78--1.49 (m, 7H), 1.47--1.35 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 75.3, 68.0, 59.4, 45.6, 36.3, 34.3, 25.0, 24.1. EIMS, 70 eV, *m*/*z* (rel. int.): 141 \[M\]^+^ (11); 96 (52); 83 (100); 82 (34); 41 (10). Anal calcd for C~8~H~15~NO: C, 68.04; H, 10.71; N, 9.92. Found: C, 68.37; H, 10.70; N, 10.14.

General Procedure vii {#sec4.6}
---------------------

Benzylcarbamate (0.6 or 0.5 mol in the case of **8m**) and trimethyl allyl silane (0.7 mol, 57.5 mL) were added to a solution of ketone **2** (0.5 mol) in dry CH~2~Cl~2~ (700 mL). The reaction mixture was cooled to 0 °C, and BF~3~·Et~2~O (0.6 mol, 98 mL or 0.5 mol, 82 mL in the case of **8m**) was added dropwise for 30 min. The mixture was stirred at 0 °C for additional 1 h and overnight at rt. The saturated aqueous solution of NaHCO~3~ (700 or 380 mL in the case of **8 m**) was added. The layers were separated; the organic layer was washed with distilled water (350 mL), dried over Na~2~SO~4~, filtered, and evaporated. The residue was purified by flash column chromatography to give the desired product.

### Benzyl (1-allylcyclobutyl)carbamate (**8b**) {#sec4.6.1}

Yield = 112.9 g, 94%, colorless oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 7.43--7.30 (m, 5H), 5.77 (m, 1H), 5.16--5.01 (m, 4H), 4.88 (s, 1H), 2.53 (d, *J* = 7.2 Hz, 2H), 2.34 (m, 2H), 2.09--2.00 (m, 2H), 1.96--1.70 (m, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.2, 136.2, 133.1, 128.1, 127.63, 127.60, 118.1, 65.8, 55.6, 41.8, 31.8, 14.0. EIMS, 70 eV, *m*/*z* (rel. int.): 245 \[M\]^+^ (2); 126 (12); 92 (10); 91 (100); 65 (11); 41 (10). Anal calcd for C~15~H~19~NO~2~: C, 73.44; H, 7.81; N, 5.71. Found: C, 73.72; H, 7.44; N, 5.97.

### Benzyl (1-allylcyclohexyl)carbamate (**8d**) {#sec4.6.2}

Yield = 101.1 g, 74%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 7.36 (m, 5H), 5.85--5.69 (m, 1H), 5.12--4.99 (m, 4H), 4.56 (s, 1H), 2.49 (d, *J* = 7.5 Hz, 2H), 1.97 (d, *J* = 12.5 Hz, 2H), 1.62--1.22 (m, 8H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.0, 136.4, 133.2, 128.1, 127.58, 127.55, 117.7, 65.7, 54.5, 42.3, 34.5, 25.5, 21.4. EIMS, 70 eV, *m*/*z* (rel. int.): 273 \[M\]^+^ (2); 232.1 (20); 188.1 (30); 124.1 (20); 91.1 (100); 81.1 (24); 79 (15). Anal calcd for C~17~H~23~NO~2~: C, 74.69; H, 8.48; N, 5.12. Found: C; 74.58; H; 8.41; N; 5.36.

### Benzyl (4-allyltetrahydro-2*H*-pyran-4-yl)carbamate (**8e**) {#sec4.6.3}

Yield = 115.64 g, 84%, white solid (mp = 49--51 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 7.32 (s, 5H), 5.71 (m, 1H), 5.10--4.97 (m, 4H), 4.66 (s, 1H), 3.78--3.52 (m, 4H), 2.48 (d, *J* = 7.5 Hz, 2H), 1.93 (d, *J* = 13.9 Hz, 2H), 1.69--1.59 (m, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.7, 136.6, 132.6, 128.5, 128.1, 128.0, 118.9, 66.2, 63.4, 52.5, 42.7, 35.0. LCMS, positive mode, *m*/*z*: 276 \[M + H\]^+^. Anal calcd for C~16~H~21~NO~3~: C, 69.79; H, 7.69; N, 5.09. Found: C, 69.69; H, 7.78; N, 5.39.

### Benzyl (1-allyl-4,4-difluorocyclohexyl)carbamate (**8o**) {#sec4.6.4}

Yield = 114.46 g, 74%, white solid (mp = 64--66 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 7.41--7.27 (m, 5H), 5.71 (m, 1H), 5.15--4.96 (m, 4H), 4.46 (s, 1H), 2.45 (d, *J* = 7.5 Hz, 2H), 2.14 (d, *J* = 14.0 Hz, 2H), 1.87 (m, 4H), 1.62 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.3, 135.9, 132.2, 128.1, 127.7, 127.6, 122.3 (t, *J* = 240.7 Hz), 118.2, 65.9, 53.2, 41.6, 30.6 (d, *J* = 7.4 Hz), 29.1 (t, *J* = 24.6 Hz). ^19^F NMR (470 MHz, chloroform-*d*) δ −93.4 (d, *J* = 236.7 Hz), −102.0 (d, *J* = 239.3 Hz). LCMS, positive mode, *m*/*z*: 310 \[M + H\]^+^. Anal calcd for C~17~H~21~F~2~NO~2~: C, 66.00; H, 6.84; N, 4.53. Found: C, 66.00; H, 7.23; N, 4.33.

### Benzyl (3-allyltetrahydro-2*H*-thiopyran-3-yl)carbamate (**8m**) {#sec4.6.5}

Yield = 100.54 g, 69%, colorless oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 7.43--7.29 (m, 5H), 5.75 (m, 1H), 5.25 (s, 1H), 5.16--5.03 (m, 4H), 2.91 (s, 1H), 2.67 (q, *J* = 13.9 Hz, 2H), 2.51 (m, 1H), 2.45 (m, 1H), 2.38 (s, 1H), 2.25 (d, *J* = 13.8 Hz, 1H), 1.82 (s, 2H), 1.29 (dt, *J* = 14.8, 7.4 Hz, 1H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.6, 136.8, 132.8, 128.5, 128.0, 127.9, 118.8, 66.2, 51.2, 42.4, 37.3, 33.5, 28.0, 23.2. EIMS, 70 eV, *m*/*z* (rel. int.): 291 \[M\]^+^ (2); 184 (24); 142 (77); 141 (11); 140 (55); 114 (11); 108 (45); 107 (30); 99 (32); 91 (100); 80 (15); 79 (54); 77 (36); 65 (19); 61 (11); 51 (14); 47 (10); 45 (11); 41 (22); 39 (22). Anal calcd for C~16~H~21~NO~2~S: C, 65.95; H, 7.26; N, 4.81; S, 11.00. Found: C ,65.93; H, 7.39; N, 4.59; S, 10.90.

General Procedure viii {#sec4.7}
----------------------

A solution of I~2~ (0.5 mol, 127 g) in THF (1900 mL) was added to a suspension of crushed NaBH~4~ (1 mol, 38 g) in THF (1100 mL). The reaction mixture was stirred for 30 min accompanied by decoloring of the solution. The solution of alkene **8**, **12**, or **17** (0.42 mol) in THF (450 mL) was added dropwise for 30 min and stirred for 90 min. The complete conversion was confirmed by TLC. A 3 M solution of NaOH (2 mol, 740 mL) was added dropwise during 2-3 h (**Caution**: exothermic process) with further dropwise addition of 30% solution of H~2~O~2~ (2 mol, 230 mL) for 1 h. The reaction mixture was stirred at rt for 1 h, diluted with brine (4400 mL), and extracted with EtOAc (3 × 1900 mL). The organic layer was evaporated with further re-dissolution of the residue in CH~2~Cl~2~ (500 mL). The organic layer was separated, dried over Na~2~SO~4~, and evaporated. The residue was purified by flash column chromatography to give the desired product.

### Benzyl (1-(3-hydroxypropyl)cyclobutyl)carbamate (**9b**) {#sec4.7.1}

Yield = 90.9 g, 75%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 7.36 (d, *J* = 4.2 Hz, 5H), 5.06 (s, 3H), 3.64 (t, *J* = 6.5 Hz, 2H), 2.23 (m, 2H), 2.01 (m, 2H), 1.81 (m, 5H), 1.53 (m, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.1, 136.2, 128.1, 127.6, 65.9, 62.6, 56.3, 33.4, 32.4, 26.9, 14.3. EIMS, 70 eV, *m*/*z* (rel. int.): 245 \[M--H~2~O\]^+^ (2); 232 (2); 100 (15); 91 (100); 65 (10). Anal calcd for C~15~H~21~NO~3~: C, 68.42; H, 8.04; N, 5.32. Found: C, 68.66; H, 8.02; N, 5.72.

### Benzyl (1-(3-hydroxypropyl)cyclohexyl)carbamate (**9d**) {#sec4.7.2}

Yield = 89.5 g, 83%, white solid (mp = 89--91 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 7.42--7.29 (m, 5H), 5.04 (s, 2H), 4.63 (s, 2H), 3.60 (t, *J* = 6.5 Hz, 2H), 1.95 (m, 2H), 1.77 (m, 2H), 1.51 (s, 6H), 1.46--1.39 (m, 2H), 1.36 (m, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.1, 136.3, 128.1, 127.61, 127,59, 65.8, 62.9, 54.4, 34.8, 34.1, 26.2, 25.5, 21.5. LCMS, positive mode, *m*/*z*: 314 \[M + Na\]^+^. Anal calcd for C~17~H~25~NO~3~: C, 70.07; H, 8.65; N, 4.81. Found: C, 69.83; H, 8.73; N, 4.62.

### Benzyl (4-(3-hydroxypropyl)tetrahydro-2*H*-pyran-4-yl)carbamate (**9e**) {#sec4.7.3}

Yield = 87.48 g, 71%, white solid (mp = 89--90 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.42--7.29 (m, 5H), 5.05 (s, 2H), 4.72 (s, 1H), 3.74 (d, *J* = 12.2 Hz, 2H), 3.64--3.56 (m, 4H) 1.96 (d, *J* = 13.9 Hz, 2H), 1.81 (m, 3H), 1.64 (m, 2H), 1.51 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.6, 136.5, 128.6, 128.2, 128.0, 66.3, 63.4, 62.9, 52.5, 35.3, 34.7, 26.1. LCMS, positive mode, m/z: 294 \[M + H\]^+^. Anal calcd for C~16~H~23~NO~4~: C, 65.51; H, 7.90; N, 4.77. Found: C, 65.64; H, 8.11; N, 5.16.

### Benzyl (4,4-difluoro-1-(3-hydroxypropyl)cyclohexyl)carbamate (**9o**) {#sec4.7.4}

Yield = 93.27 g, 77%, white solid (mp = 97--98 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 7.35 (m, 5H), 5.05 (s, 2H), 4.58 (s, 1H), 3.61 (t, *J* = 6.5 Hz, 2H), 2.16 (d, *J* = 14.1 Hz, 2H), 1.93 (m, 3H), 1.77 (m, 2H), 1.64 (m, 2H), 1.51 (m, 3H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.8, 136.3, 128.6, 128.3, 128.1, 122.9 (t, *J* = 241.9 Hz), 66.5, 62.8, 53.6, 34.0, 31.3 (d, *J* = 6.3 Hz), 29.6 (t, *J* = 24.6 Hz), 26.7. ^19^F NMR (470 MHz, chloroform-*d*) δ −93.4 (d, *J* = 234.3 Hz), −102.1 (d, *J* = 240.1 Hz). LCMS, positive mode, *m*/*z*: 350 \[M + Na\]^+^. Anal calcd for C~17~H~23~F~2~NO~3~: C, 62.37; H, 7.08; N, 4.28. Found: C, 62.61; H, 7.08; N, 4.05.

### Benzyl (3-(3-hydroxypropyl)tetrahydro-2*H*-thiopyran-3-yl)carbamate (**9m**) {#sec4.7.5}

Yield = 81.13 g, 76%, white solid (mp = 80--81 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.40--7.28 (m, 5H), 5.33 (s, 1H), 5.06 (s, 2H), 3.61 (t, *J* = 6.4 Hz, 2H), 2.64 (q, *J* = 13.8 Hz, 2H), 2.52 (m, 1H), 2.45 (dt, *J* = 13.6, 4.2 Hz, 1H), 2.25--2.15 (m, 2H), 1.80 (m, 3H), 1.62 (m, 1H), 1.52 (dq, *J* = 14.9, 6.7 Hz, 2H), 1.26 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.7, 136.7, 128.5, 128.0, 128.0, 66.2, 62.8, 51.9, 37.5, 34.4, 34.0, 28.1, 26.0, 23.2. LCMS, positive mode, *m*/*z*: 310 \[M + H\]^+^. Anal calcd for C~16~H~23~NO~3~S: C, 62.11; H, 7.49; N, 4.53; S, 10.36. Found: C, 61.73; H, 7.66; N, 4.22; S, 10.17.

### Ethyl (4-(3-hydroxypropyl)tetrahydro-2*H*-thiopyran-4-yl)carbamate (**13f**) {#sec4.7.6}

Yield = 60.55 g, 72%, white solid (mp = 82--83 °C). ^1^H NMR (500 MHz, DMSO-*d*~6~) δ 4.40 (s, 1H), 4.06 (t, *J* = 7.3 Hz, 2H), 3.63 (t, *J* = 6.5 Hz, 2H), 2.78 (ddd, *J* = 14.0, 11.1, 2.8 Hz, 2H), 2.47 (dt, *J* = 14.3, 4.3 Hz, 2H), 2.29 (d, *J* = 13.9 Hz, 2H), 1.84--1.68 (m, 4H), 1.59--1.47 (m, 2H), 1.24 (dt, *J* = 14.1, 7.0 Hz, 3H); the proton of the OH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.3, 62.4, 59.9, 52.9, 35.4, 34.4, 25.5, 23.1, 14.1. LCMS, positive mode, m/z: 159.2 \[M--NCOOEt\]^+^. Anal calcd. for C~11~H~21~NO~3~S: C, 53.41; H, 8.56; N, 5.66; S, 12. 96. Found: C, 53.50; H, 8.43; N, 5.47; S, 13.36.

### Ethyl (3-(3-hydroxypropyl)tetrahydro-2*H*-thiopyran-3-yl)carbamate (**13m**) {#sec4.7.7}

Yield = 71.43 g, 76%, yellow oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 5.21 (s, 1H), 4.06 (q, *J* = 7.3 Hz, 2H), 3.63 (t, *J* = 6.3 Hz, 2H), 2.64 (q, *J* = 13.7 Hz, 2H), 2.56--2.42 (m, 2H), 2.18 (s, 2H), 1.81 (s, 3H), 1.57 (d, *J* = 27.4 Hz, 3H), 1.26--1.20 (m, 3H); the proton of the OH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.6, 62.4, 59.9, 51.2, 37.1, 33.9, 33.6, 27.6, 25.5, 22.7, 14.1. EIMS, 70 eV, *m*/*z* (rel. int.): 247 \[M\]^+^ (5); 159 (15); 158 (100); 140 (11); 129 (29); 127 (13); 122 (15); 113 (35); 101 (13); 100 (11); 99 (18); 97 (63); 96 (10); 84 (10); 82 (18); 79 (12); 74 (20); 61 (17); 57 (17); 55 (13); 54 (10); 47 (10); 46 (13); 45 (24); 43 (10); 42 (18); 41 (31); 39 (12). Anal calcd for C~11~H~21~NO~3~S: C, 53.41; H, 8.56; N, 5.66; S, 12.96. Found: C, 53.45; H, 8.44; N, 6.02; S, 12.84.

### *tert*-Butyl (4-(3-hydroxypropyl)tetrahydro-2*H*-thiopyran-4-yl)carbamate (**18f**) {#sec4.7.8}

Yield = 75.40 g, 74%, white solid (mp = 147--148 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 4.26 (s, 1H), 3.64 (t, *J* = 6.5 Hz, 2H), 2.80 (ddd, *J* = 14.1, 11.4, 2.6 Hz, 2H), 2.47 (dt, *J* = 14.4, 4.1 Hz, 2H), 2.28 (dd, *J* = 13.7, 4.2 Hz, 2H), 1.82--1.65 (m, 4H), 1.60--1.49 (m, 3H), 1.43 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.3, 79.2, 63.0, 53.2, 36.0, 34.9, 28.4, 26.0, 23.6. EIMS, 70 eV, m/z (rel. Int.): 275 \[M\]^+^ (2); 207 (11); 201 (15); 173 (10); 160 (20); 159 (11); 158 (24); 157 (15); 140 (27); 130 (24); 114 (13); 112 (31); 99 (61); 97 (28); 83 (10); 82 (14); 79 (12); 59 (39); 57 (44); 56 (50); 55 (24); 54 (10); 53 (12); 45 (10); 44 (70); 43 (13); 42 (11); 41 (100); 40 (19); 39 (47). Anal calcd for C~13~H~25~NO~3~S: C, 56.69; H, 9.15; N, 5.09; S, 11.64. Found: C, 56.68; H, 9.33; N, 4.79; S, 11.60.

### *tert*-Butyl (3-(3-hydroxypropyl)tetrahydrothiophen-3-yl)carbamate (**18k**) {#sec4.7.9}

Yield = 82.60 g, 79%, white powder, (mp = 101--102 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 4.65 (s, 1H), 3.63 (t, *J* = 6.4 Hz, 2H), 2.84 (m, 3H), 2.75 (d, *J* = 11.4 Hz, 1H), 2.60--2.49 (m, 1H), 2.22 (t, *J* = 11.3 Hz, 1H), 1.81--1.51 (m, 5H), 1.40 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.7, 79.4, 66.0, 62.9, 41.5, 39.6, 31.6, 28.7, 28.4, 28.4. LCMS, positive mode, m/z: 284 \[M + Na\]^+^. Anal calcd for C~12~H~23~NO~3~S: C, 55.14; H, 8.87; N, 5.36; S, 12.27. Found: C, 55.51; H, 9.20; N, 5.01; S, 12.07.

### *tert*-Butyl 4-(3-hydroxypropyl)-4-(2,2,2-trifluoroacetamido)piperidine-1-carboxylate (**18p**) {#sec4.7.10}

Yield = 100.66 g, 65%, white solid (mp = 86--87 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 6.47 (m, 1H), 3.81--3.68 (s, 2H), 3.63 (q, *J* = 6.3, 5.9 Hz, 2H), 3.09 (t, *J* = 12.9 Hz, 2H), 2.18 (s, 2H), 1.88 (s, 2H), 1.67--1.48 (m, 4H), 1.48--1.39 (m, 9H); the proton of the OH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 157.2--156.3 (m), 154.7, 115.5 (q, *J* = 289.8 Hz), 80.0, 62.4 (q, *J* = 4.2, 3.7 Hz), 56.0, 39.4, 33.5, 33.4, 28.4, 25.9. ^19^F NMR (470 MHz, chloroform-*d*) δ −75.8 (m). EIMS, 70 eV, m/z (rel. int.): 377 \[M + Na\]^+^ (2); 279 (52); 263 (42); 262 (25); 236 (12); 235 (59); 192 (13); 139 (34); 126 (11); 108 (15); 96 (27); 95 (16); 83 (14); 82 (98); 69 (15); 57 (100); 55 (15); 44 (23); 41 (64); 39 (31). Anal calcd for C~15~H~25~F~3~N~2~O~4~: C, 50.84; H, 7.11; N, 7.91. Found: C, 50.60; H, 6.89; N, 7.93.

### *tert*-Butyl 3-(3-hydroxypropyl)-3-(2,2,2-trifluoroacetamido)piperidine-1-carboxylate (**18r**) {#sec4.7.11}

Yield = 90.96 g, 62%, white solid (mp = 127--128 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 6.51 (s, 1H), 4.20 (d, *J* = 13.5 Hz, 1H), 3.97 (dt, *J* = 13.7, 3.9 Hz, 1H), 3.63 (m, 2H), 2.90--2.37 (m, 3H), 2.06 (d, *J* = 75.3 Hz, 3H), 1.53 (s, 5H), 1.46 (s, 9H); the proton of the OH group is not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 156.8 (m), 154.4, 115.5 (q, *J* = 289.3 Hz), 80.9, 62.4, 57.9, 51.6, 45.6, 32.2, 31.5, 28.2, 26.0, 21.7. ^19^F NMR (470 MHz, chloroform-*d*) δ −75.9, −76.2 LCMS, negative mode, *m*/*z*: 353.2 \[M--H\]^−^. Anal calcd for C~15~H~25~F~3~N~2~O~4~: C, 50.84; H, 7.11; N, 7.91. Found: C, 50.52; H, 7.10; N, 7.88.

### *tert*-Butyl (1-(3-hydroxypropyl)cyclopropyl)carbamate (**18a**) {#sec4.7.12}

Yield = 127.0 g, 59%, white solid (mp = 55--57 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 4.93 (s, 1H), 3.62 (t, *J* = 6.3 Hz, 2H), 1.70--1.60 (m, 2H), 1.55 (s, 2H), 1.39 (s, 9H), 0.70 (m, 2H), 0.57 (m, 2H), the proton of the OH group is not observed due to the exchange. ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 155.5, 79.2, 62.7, 33.2, 32.8, 29.5, 28.4, 14.0. EIMS, 70 eV, *m*/*z* (rel. int.): 159 \[M-C(CH~3~)~3~ + H\]^+^ (4); 98 (41); 84 (25); 71 (37); 59 (25); 57 (100); 56 (21); 55 (11); 54 (12); 44 (10); 42 (10); 41 (45); 39 (17). Anal calcd for C~11~H~21~NO~3~: C, 61.37; H, 9.83; N, 6.51. Found: C, 61.37; H, 10.14; N, 6.74.

General Procedure ix {#sec4.8}
--------------------

*i*-Pr~2~NEt (0.35 mol, 34 mL) (triethylamine (0.35 mol, 26 mL) in the case of **19k**) was added to a solution of alcohol **9**, **13**, or **18** (0.30 mmol) in CH~2~Cl~2~ (1400 mL). The reaction mixture was cooled to 0 °C, and a solution of methanesulfonyl chloride (0.31 mol, 53 mL) in CH~2~Cl~2~ (140 mL) was added dropwise for 45 min. The mixture was further stirred at 0 °C for 30 min and overnight at rt. In the case of **19a**, the solution was stirred for 3 h at ambient temperature, and complete conversion was confirmed by NMR spectroscopy. An aqueous solution of citric acid (10%, 1000 mL) was added and stirred for 10 min. Layers were separated; the organic layer was washed with a saturated aqueous solution of NaHCO~3~ (560 mL) and brine (560 mL) (only a solution of NaHCO~3~ was used in the case of **19a**). The organic layer was dried over Na~2~SO~4~ and evaporated. The residue was used in the next step without further purification.

In the case of **19r** and **19p**, the alcohol (0.257 mol) was dissolved in dry CH~2~Cl~2~ (1250 mL), and then DIPEA (0.308 mol, 30 mL) and mesyl chloride (0.27 mol, 46 mL) were added. The reaction mixture was stirred overnight, washed with 10% citric acid solution (200 mL), dried over Na~2~SO~4~, and evaporated.

The analytical samples were additionally purified by flash column chromatography.

### 3-(1-(((Benzyloxy)carbonyl)amino)cyclobutyl)propyl methanesulfonate (**10b**) {#sec4.8.1}

Yield = 108.7 g, 91%, light yellow viscous oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 7.40--7.28 (m, 5H), 5.05 (s, 2H), 4.96 (s, 1H), 4.21 (t, *J* = 6.6 Hz, 2H), 2.96 (s, 3H), 2.14 (m, 2H), 2.08--1.99 (m, 2H), 1.97--1.75 (m, 4H), 1.75--1.66 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.9, 136.0, 128.1, 127.63, 127.57, 69.7, 65.8, 55.8, 36.9, 32.6, 32.3, 23.5, 14.1. LCMS, positive mode, *m*/*z*: 342 \[M + H\]^+^. Anal calcd for C~16~H~23~NO~5~S: C, 56.29; H, 6.79; N, 4.10; S, 9.39. Found: C, 55.96; H, 6.39; N, 4.37; S, 9.18.

### 3-(1-(((Benzyloxy)carbonyl)amino)cyclohexyl)propyl methanesulfonate (**10d**) {#sec4.8.2}

Yield = 100.5 g, 85%, white solid (mp = 65--67 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.40--7.28 (m, 5H), 5.04 (s, 2H), 4.56 (s, 1H), 4.18 (d, *J* = 6.8 Hz, 2H), 2.96 (d, *J* = 2.9 Hz, 3H), 1.93 (d, *J* = 12.9 Hz, 2H), 1.80 (d, *J* = 9.2 Hz, 2H), 1.71 (d, *J* = 3.5 Hz, 2H), 1.61--1.20 (m, 8H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.4, 136.7, 128.5, 128.1, 128.0, 70.5, 66.1, 54.3, 37.4, 34.9, 34.1, 25.6, 23.3, 21.5. LCMS, positive mode, *m*/*z*: 370 \[M + H\]^+^. Anal calcd for C~18~H~27~NO~5~S: C, 58.51; H, 7.37; N, 3.79; S, 8.68. Found: C, 58.32; H, 7.77; N, 3.89; S, 8.37.

### 3-(4-(((Benzyloxy)carbonyl)amino)tetrahydro-2*H*-pyran-4-yl)propyl methanesulfonate (**10e**) {#sec4.8.3}

yield = 105.86 g, 95%, white solid (mp = 76--77 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.42--7.28 (m, 5H), 5.05 (s, 2H), 4.73 (s, 1H), 4.19 (t, *J* = 6.1 Hz, 2H), 3.74 (d, *J* = 8.4 Hz, 2H), 3.59 (t, *J* = 10.5 Hz, 2H), 2.96 (s, 3H), 1.95 (d, *J* = 13.9 Hz, 2H), 1.85 (m, 2H), 1.71 (m, 2H), 1.63 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.5, 136.4, 128.6, 128.2, 128.0, 70.0, 66.4, 63.3, 52.3, 37.4, 35.1, 34.5, 23.0. LCMS, positive mode, *m*/*z*: 372 \[M + H\]^+^. Anal calcd for C~17~H~25~NO~6~S: C, 54.97; H, 6.78; N, 3.77; S, 8.63. Found: C, 54.57; H, 7.10; N, 3.54; S, 8.69.

### 3-(1-(((Benzyloxy)carbonyl)amino)-4,4-difluorocyclohexyl)propyl methanesulfonate (**10o**) {#sec4.8.4}

Yield = 112.09 g, 97%, white solid (mp = 73--75 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 7.34 (dt, *J* = 9.2, 4.3 Hz, 5H), 5.03 (s, 2H), 4.60 (s, 1H), 4.16 (t, *J* = 6.2 Hz, 2H), 2.94 (s, 3H), 2.13 (d, *J* = 12.4 Hz, 2H), 1.98--1.76 (m, 6H), 1.69 (m, 2H), 1.59 (m, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.7, 136.3, 128.6, 128.3, 128.1, 121.9 (t, *J* = 241.9 Hz), 69.9, 66.5, 53.3, 37.4, 33.8, 31.2 (d, *J* = 7.1 Hz), 29.5 (t, *J* = 24.6 Hz), 23.6. ^19^F NMR (470 MHz, chloroform-*d*) δ −93.4 (d, *J* = 237.1 Hz), −102.4 (d, *J* = 240.5 Hz). LCMS, positive mode, m/z: 406 \[M + H\]^+^. Anal calcd for C~18~H~25~F~2~NO~5~S: C, 53.32; H, 6.21; N, 3.45; S, 7.91. Found: C, 53.56; H, 5.85; N, 3.43; S, 7.97.

### 3-(3-(((Benzyloxy)carbonyl)amino)tetrahydro-2*H*-thiopyran-3-yl)propyl methanesulfonate (**10m**) {#sec4.8.5}

Yield = 98.74 g, 98%, yellow oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 7.41--7.29 (m, 5H), 5.30 (s, 1H), 5.11--5.04 (m, 2H), 4.27--4.14 (m, 2H), 2.97 (d, *J* = 3.3 Hz, 3H), 2.64 (s, 2H), 2.58--2.42 (m, 2H), 2.30--2.14 (m, 2H), 1.86--1.61 (m, 5H), 1.31--1.22 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.2, 136.1, 128.1, 127.6, 127.4, 69.7, 65.8, 51.2, 37.0, 36.9, 33.6, 33.5, 27.6, 22.6, 22.4. LCMS, positive mode, *m*/*z*: 389 \[M + H\]^+^; 388 \[M\]^+^. Anal calcd for C~17~H~25~NO~5~S~2~: C, 52.69; H, 6.50; N, 3.61; S, 16.55. Found: C, 52.54; H, 6.72; N, 3.61; S, 16.86.

### 3-(4-((Ethoxycarbonyl)amino)tetrahydro-2*H*-thiopyran-4-yl)propyl methanesulfonate (**14f**) {#sec4.8.6}

Yield = 67.17 g, 86%, brown oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 5.27 (d, *J* = 2.9 Hz, 1H), 4.18 (m, 2H), 4.01 (m, 2H), 2.97 (d, *J* = 2.8 Hz, 3H), 2.85--2.65 (m, 2H), 2.43 (dd, *J* = 14.4, 4.0 Hz, 2H), 2.26 (d, *J* = 13.9 Hz, 2H), 1.78 (m, 2H), 1.69 (tt, *J* = 11.4, 3.3 Hz, 4H), 1.20 (td, *J* = 7.1, 2.9 Hz, 3H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.1, 69.6, 60.0, 52.7, 44.7, 38.9, 36.9, 35.3, 34.2, 23.0, 22.4, 14.1. LCMS, positive mode, *m*/*z*: 237.2 \[M--NCOOEt\]^+^. Anal calcd for C~12~H~23~NO~5~S~2~: C, 44.29; H, 7.12; N, 4.30; S, 19.70. Found: C, 44.13; H, 7.31; N, 4.68; S, 19.87.

### 3-(3-((Ethoxycarbonyl)amino)tetrahydro-2*H*-thiopyran-3-yl)propyl methanesulfonate (**14m**) {#sec4.8.7}

Yield = 83.05 g, 88%, brown oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 5.29 (s, 1H), 4.20 (m, 2H), 4.06 (q, *J* = 7.1 Hz, 2H), 2.99 (s, 3H), 2.62 (s, 2H), 2.57--2.42 (m, 2H), 2.27--2.13 (m, 2H), 1.80 (m, 2H), 1.73 (m, 2H), 1.68--1.60 (m, 2H), 1.23 (t, *J* = 7.0 Hz, 3H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.9, 70.3, 60.3, 53.6, 51.4, 37.3, 34.0, 33.9, 28.0, 23.1, 22.9, 14.6. EIMS, 70 eV, *m*/*z* (rel. int.): 229 (27); 169 (10); 168 (100); 155 (52); 140 (14); 127 (10); 113 (13); 83 (67); 83 (28); 80 (10); 67 (10); 55 (18); 54 (11); 45 (12); 42 (11); 41 (26); 39 (12). Anal calcd for C~12~H~23~NO~5~S~2~: C, 44.29; H, 7.12; N, 4.30; S, 19.70. Found: C, 44.25; H, 7.37; N, 4.26; S, 19.74.

### 3-(4-((*tert*-Butoxycarbonyl)amino)tetrahydro-2*H*-thiopyran-4-yl)propyl methanesulfonate (**19f**) {#sec4.8.8}

Yield = 93.54 g, 98%, yellow solid (mp = 88--89 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 4.29 (s, 1H), 4.17 (t, *J* = 6.2 Hz, 2H), 2.96 (s, 3H), 2.75 (t, *J* = 11.6 Hz, 2H), 2.41 (d, *J* = 14.5 Hz, 2H), 2.24 (d, *J* = 14.0 Hz, 2H), 1.68 (m, 6H), 1.38 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.1, 79.3, 70.2, 53.0, 37.4, 35.9, 34.7, 28.4, 23.5, 23.0. EIMS, 70 eV, *m*/*z* (rel. int.): 377 \[M + Na\]^+^ (1); 363 (1); 257 (12); 201 (42); 184 (13); 173 (29); 140 (28); 129 (31); 128 (11); 97 (12); 96 (100); 83 (35); 82 (12); 57 (46); 56 (16); 44 (12); 41 (39); 39 (17). Anal calcd for C~14~H~27~NO~5~S~2~: C, 47.57; H, 7.70; N, 3.96; S, 18.14. Found: C, 47.61; H, 7.71; N, 4.04; S, 17.74.

### 3-(3-((*tert*-Butoxycarbonyl)amino)tetrahydrothiophen-3-yl)propyl methanesulfonate (**19k**) {#sec4.8.9}

Yield = 108.63 g, 100%, brown powder (mp = 84--85 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 4.65 (s, 1H), 4.23 (dq, *J* = 6.9, 4.8, 4.2 Hz, 2H), 2.99 (s, 3H), 2.89--2.82 (m, 3H), 2.76 (d, *J* = 11.2 Hz, 1H), 2.55 (d, *J* = 11.6 Hz, 1H), 2.29 (d, *J* = 13.3 Hz, 1H), 1.88--1.67 (m, 4H), 1.42 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.6, 79.6, 70.0, 65.7, 41.4, 39.6, 37.5, 31.4, 28.6, 28.4, 25.2. LCMS, positive mode, *m*/*z*: \[M + Na\]^+^. Anal Calcd for C~13~H~25~NO~5~S~2~: C, 46.00; H, 7.42; N, 4.13; S, 18.89. Found: C, 46.17; H, 7.04; N, 4.16; S, 19.2.

### *tert*-Butyl-4-(3-((methylsulfonyl)oxy)propyl)-4-(2,2,2-trifluoroacetamido)piperidine-1-carboxylate (**19p**) {#sec4.8.10}

Yield = 113.0 g, 92%, beige solid (mp = 121--122 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 6.16 (s, 1H), 4.22 (t, *J* = 5.9 Hz, 2H), 3.83 (s, 2H), 3.08--2.94 (m, 5H), 2.14 (s, 2H), 2.01--1.90 (s, 2H), 1.73 (m, 2H), 1.60 (ddd, *J* = 14.5, 11.3, 4.2 Hz, 2H), 1.45 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 156.6 (q, *J* = 36.2 Hz), 154.6, 115.5 (q, *J* = 289.4 Hz), 80.1, 69.4, 55.7, 39.3, 37.5, 33.7, 33.3, 28.4, 23.2. ^19^F NMR (470 MHz, chloroform-*d*) δ −75.7. LCMS, positive mode, *m*/*z*: 333 \[M--Boc + 1\]. Anal calcd for C~16~H~27~F~3~N~2~O~6~S: C, 44.44; H, 6.29; N, 6.48; S, 7.41. Found: C, 44.66; H, 6.30; N, 6.18; S, 7.06.

### *tert*-Butyl 3-(3-((methylsulfonyl)oxy)propyl)-3-(2,2,2-trifluoroacetamido)piperidine-1-carboxylate (**19r**) {#sec4.8.11}

Yield = 100.0 g, 90%, yellow solid (mp = 93--94 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 6.27 (s, 1H), 4.22 (m, 3H), 4.02 (d, *J* = 13.4 Hz, 1H), 3.00 (s, 3H), 2.78 (m, 2H), 2.40 (br m, 1H), 1.86--1.63 (m, 2H), 1.56 (s, 3H), 1.45 (s, 11H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 156.7 (q, *J* = 37.2 Hz), 154.0, 115.4 (q, *J* = 289.1 Hz), 81.1, 69.4, 57.6, 51.7, 45.7, 37.4, 31.8, 31.5, 28.2, 23.1, 21.7. ^19^F NMR (470 MHz, chloroform-*d*) δ −75.9, −76.2. LCMS, positive mode, *m*/*z*: 377.0 \[M--C(CH~3~)~3~\]^+^; 333.2 \[M--Boc\]^+^. Anal calcd for C~16~H~27~F~3~N~2~O~6~S: C, 44.44; H, 6.29; N, 6.48; S, 7.41. Found: C, 44.31; H, 5.97; N, 6.24; S, 7.63.

### 3-(1-((*tert*-Butoxycarbonyl)amino)cyclopropyl)propyl methanesulfonate (**19a**) {#sec4.8.12}

Yield = 164.4 g, 95%, beige solid (mp = 52--53 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 4.85 (s, 1H), 4.24 (t, *J* = 6.5 Hz, 2H), 2.96 (s, 3H), 1.86 (dt, *J* = 14.6, 6.6 Hz, 2H), 1.60 (m, 2H), 1.38 (s, 9H), 0.73 (m, 2H), 0.59 (q, *J* = 5.0 Hz, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 155.5, 79.3, 70.0, 37.3, 32.8, 32.3, 28.4, 26.3, 14.0. EIMS, 70 eV, *m*/*z* (rel. int.): 141 (48); 140 (13); 97 (28); 96 (86); 69 (10); 57 (100); 56 (10); 41 (48); 39 (15). Anal calcd for C~12~H~23~NO~5~S: C, 49.13; H, 7.90; N, 4.77; S, 10.93. Found: C, 49.42; H, 8.05; N, 4.57; S, 10.71.

General Procedure x {#sec4.9}
-------------------

NaH (60% in mineral oil, 0.48 mol, 11.5 g) was added in portions of solutions of mesylate **10**, **14**, or **19** (0.32 mol) in THF (3200 mL) over 30 min. The reaction mixture was heated to 60 °C and was stirred overnight at this temperature. Then, THF was evaporated and a saturated aqueous solution of NH~4~Cl (1600 mL) was carefully added. In the case of **20a**, **20r**, and **20p**, distilled water (1420 mL) instead of an aqueous solution of NH~4~Cl was used. The product was extracted with CH~2~Cl~2~ (3 × 600 mL). The organic layer was dried over Na~2~SO~4~ and evaporated. The residue was purified by flash column chromatography to give the desired product.

### Benzyl 5-azaspiro\[3.4\]octane-5-carboxylate (**11b**) {#sec4.9.1}

Yield = 72.2 g, 92%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 7.49--7.28 (m, 5H), 5.23--5.13 (m, 2H), 3.42 (m, 2H), 3.14--2.86 (m, 2H), 2.04 (m, 2H), 1.86--1.57 (m, 6H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.4, 137.3, 128.4, 127.9, 127.8, 66.0, 63.5, 48.0, 40.1, 32.6, 22.1, 13.6. EIMS, 70 eV, *m*/*z* (rel. int.): 245 \[M\]^+^ 217 (11); 172 (18); 92 (11); 91 (100); 65 (14). Anal calcd for C~15~H~19~NO~2~: C, 73.44; H, 7.81; N, 5.71. Found: C, 73.69; H, 7.57; N, 5.86.

### Benzyl 1-azaspiro\[4.5\]decane-1-carboxylate (**11d**) {#sec4.9.2}

Yield = 63.5 g, 86%, white solid (mp = 55--56 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.45--7.29 (m, 5H), 5.18--5.09 (m, 2H), 3.51 (dt, *J* = 21.3, 6.7 Hz, 2H), 2.56--2.19 (m, 2H), 1.88 (m, 2H), 1.67 (m, 6H), 1.37 (m, 2H), 1.28 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.1, 136.9, 127.9, 127.22, 127.16, 65.3, 64.1, 47.2, 35.4, 32.9, 24.7, 23.8, 21.9. LCMS, positive mode, *m*/*z*: 274 \[M + H\]^+^. Anal calcd for C~17~H~23~NO~2~: C, 74.69; H, 8.48; N, 5.12. Found: C, 74.52; H, 8.24; N, 5.36.

### Benzyl 8-oxa-1-azaspiro\[4.5\]decane-1-carboxylate (**11e**) {#sec4.9.3}

Yield = 51.84 g, 82%, white solid (mp = 94--95 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.42--7.33 (m, 4H), 7.30 (t, *J* = 6.8 Hz, 1H), 5.16 (m, 2H), 3.94 (m, 2H), 3.52 (m, 2H), 3.44 (t, *J* = 12.4 Hz, 2H), 2.98--2.60 (m, 2H), 1.98 (m, 2H), 1.79 (p, *J* = 6.6 Hz, 2H), 1.24 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.6, 137.2, 128.4, 127.9, 127.8, 66.0, 61.9, 47.6, 35.4, 35.3, 34.1, 22.2. LCMS, positive mode, m/z: 276 \[M + H\]^+^. Anal calcd for C~16~H~21~NO~3~: C, 69.79; H, 7.69; N, 5.09. Found: C, 69.47; H, 7.37; N, 4.99.

### Benzyl 8,8-difluoro-1-azaspiro\[4.5\]decane-1-carboxylate (**11o**) {#sec4.9.4}

Yield = 75.71 g, 89%, white solid (mp = 128--130 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.36 (s, 4H), 7.30 (s, 1H), 5.14 (m, 2H), 3.54 (s, 2H), 2.97--2.60 (m, 2H), 2.09 (s, 2H), 1.93 (m, 2H), 1.89--1.70 (m, 4H), 1.41 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.0, 136.6, 127.9, 127.32, 127.26, 122.0 (t, *J* = 241.6 Hz), 65.6, 62.4, 47.2, 34.8, 31.3 (t, *J* = 24.7 Hz), 28.8 (d, *J* = 10.0 Hz), 21.8. ^19^F NMR (470 MHz, chloroform-*d*) δ −93.3 (d, *J* = 235.5 Hz), −102.8 (m). EIMS, 70 eV, *m*/*z* (rel. int.): 309 \[M\]^+^ (20); 186 (45); 91 (100). Anal calcd for C~17~H~21~F~2~NO~2~: C, 66.00; H, 6.84; N, 4.53. Found: C, 65.72; H, 6.44; N, 4.31.

### Benzyl 7-thia-1-azaspiro\[4.5\]decane-1-carboxylate (**11m**) {#sec4.9.5}

Yield = 54.25 g, 73%, yellowish solid (mp = 61--63 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.36 (t, *J* = 7.2 Hz, 5H), 5.13 (d, *J* = 46.6 Hz, 2H), 3.78--3.40 (m, 2H), 2.71--2.55 (m, 2H), 2.47 (m, 1H), 2.38 (d, *J* = 12.9 Hz, 2H), 2.12 (d, *J* = 12.8 Hz, 1H), 2.05 (dt, *J* = 13.5, 3.5 Hz, 1H), 1.92 (dt, *J* = 13.4, 7.8 Hz, 1H), 1.78 (m, 3H), 1.49 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.3, 136.6, 127.9, 127.3, 127.2, 65.7, 62.9, 47.7, 35.2, 33.40, 33.35, 27.1, 26.5, 21.7. LCMS, positive mode, *m*/*z*: 292 \[M + H\]^+^. Anal calcd for C~16~H~21~NO~2~S: C, 65.95; H, 7.26; N, 4.81; S, 11.00. Found: C, 66.13; H, 7.60; N, 5.13; S, 10.69.

### Ethyl 8-thia-1-azaspiro\[4.5\]decane-1-carboxylate (**15f**) {#sec4.9.6}

Yield = 34.86 g, 76%, white solid, (mp = 67--68 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 4.19 (q, *J* = 7.2 Hz, 1H), 4.07 (q, *J* = 7.2 Hz, 1H), 3.50 (t, *J* = 6.9 Hz, 1H), 3.43 (t, *J* = 6.7 Hz, 1H), 2.86 (dt, *J* = 13.2, 8.1 Hz, 1H), 2.76 (t, *J* = 13.1 Hz, 2H), 2.68--2.58 (m, 1H), 2.54 (d, *J* = 13.4 Hz, 2H), 1.86 (dt, *J* = 23.1, 6.9 Hz, 2H), 1.74 (p, *J* = 6.9 Hz, 2H), 1.65 (t, *J* = 15.6 Hz, 2H), 1.30 (t, *J* = 7.4 Hz, 1H), 1.23 (t, *J* = 7.0 Hz, 2H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 149.2, 58.3, 55.4, 42.7, 31.0, 29.9, 22.1, 17.4, 10.1. LCMS, positive mode, *m*/*z*: 230.0 \[M + H\]^+^. Anal calcd for C~11~H~19~NO~2~S: C, 57.61; H, 8.35; N, 6.11; S, 13.98. Found: C, 57.71; H, 8.22; N, 6.07; S, 14.16.

### Ethyl 7-thia-1-azaspiro\[4.5\]decane-1-carboxylate (**15m**) {#sec4.9.7}

Yield = 40.94 g, 70%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 4.04 (m, 2H), 3.68 (d, *J* = 13.0 Hz, 1H), 3.47 (m, 2H), 2.58 (m, 2H), 2.35 (m, 2H), 2.15--1.94 (m, 2H), 1.94--1.63 (m, 4H), 1.44 (m, 1H), 1.22 (m, 3H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.6, 62.6, 59.8, 47.6, 35.2, 33.4, 33.3, 27.1, 26.5, 21.7, 14.2. EIMS, 70 eV, *m*/*z* (rel. int.): 231 (2); 230 \[M + H\]^+^ (5); 229 \[M\]^+^ (41); 168 (100); 155 (48); 140 (10); 96 (15); 83 (29); 82 (13). Anal calcd for C~11~H~19~NO~2~S: C, 57.61; H, 8.35; N, 6.11; S, 13.98. Found: C, 57.77; H, 8.25; N, 6.09; S, 14.29.

### *tert*-Butyl 8-thia-1-azaspiro\[4.5\]decane-1-carboxylate (**20f**) {#sec4.9.8}

Yield = 50.86 g, 76%, white solid (mp = 89--90 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 3.43 (d, *J* = 36.8 Hz, 2H), 2.89 (m, 1H), 2.76 (t, *J* = 13.2 Hz, 2H), 2.63 (m, 1H), 2.55 (d, *J* = 13.2 Hz, 2H), 1.85 (m, 2H), 1.72 (p, *J* = 7.0 Hz, 2H), 1.65 (s, 2H), 1.49 (d, *J* = 34.4 Hz, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.3, 153.3\*, 79.8, 78.7\*, 62.7\*, 62.3, 47.9, 36.1\*, 35.8, 35.1\*, 34.7, 28.6, 27.0, 26.9\*, 22.0\*, 21.5 (\*due to hindered rotation). EIMS, 70 eV, m/z (rel. int.): 259 (1); 258 \[M + H\]^+^ (2); 257 \[M\]^+^ (13); 201 (46); 184 (14); 173 (33); 140 (33); 129 (28); 128 (12); 97 (13); 96 (100); 83 (34); 82 (12); 57 (55); 44 (12); 41 (42); 39 (18). Anal calcd for C~13~H~23~NO~2~S: C, 60.66; H, 9.01; N, 5.44. Found: C, 60.36; H, 9.10; N, 5.82; S, 12.34.

### *tert*-Butyl 7-thia-1-azaspiro\[4.4\]nonane-1-carboxylate (**20k**) {#sec4.9.9}

Yield = 60.75 g, 78%, white powder (mp = 69--70 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 3.60--3.27 (m, 3H), 3.03--2.65 (m, 3H), 2.40--2.05 (m, 2H), 1.82--1.59 (m, 4H), 1.44 (d, *J* = 11.9 Hz, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.8\*, 153.1, 80.1\*, 79.2, 72.2, 71.6\*, 48.5, 40.1\*, 38.9, 38.0\*, 36.8\*, 36.5, 36.0, 28.6, 27.8, 22.3, 21.8\* (\*due to hindered rotation). EIMS, 70 eV, m/z (rel. int.): 245 (2); 244 \[M + H\]^+^ (3); 243 \[M\]^+^ (20); 188 (10); 187 (96); 170 (25); 142 (12); 140 (15); 128 (18); 126 (72); 125 (10); 115 (10); 99 (22); 97 (48); 96 (90); 86 (15); 82 (13); 57 (100); 56 (20); 55 (12); 45 (12); 41 (70); 39 (29). Anal calcd for C~12~H~21~NO~2~S: C, 59.22; H, 8.70; N, 5.76; S, 13.17. Found: C, 59.19; H, 8.66; N, 6.10; S, 12.83.

### *tert*-Butyl-1-(2,2,2-trifluoroacetyl)-1,8-diazaspiro\[4.5\]decane-8-carboxylate (**20p**) {#sec4.9.10}

Yield = 76.96 g, 88%, white vitreous solid. ^1^H NMR (400 MHz, chloroform-*d*) δ 4.14 (s, 2H), 3.67 (t, *J* = 6.4 Hz, 2H), 2.90--2.67 (m, 4H), 2.03--1.85 (m, 4H), 1.43 (s, 9H), 1.29 (d, *J* = 12.3 Hz, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 155.0 (q, *J* = 36.0 Hz), 154.5, 116.1 (q, *J* = 289.0 Hz), 79.7, 67.1, 48.0 (q, *J* = 4.0 Hz), 41.5 (d, *J* = 98.9 Hz), 34.5, 31.6, 28.4, 23.2. ^19^F NMR (470 MHz, chloroform-*d*) δ −72.8. LCMS, positive mode, *m*/*z*: 359 \[M + Na\]^+^. Anal calcd for C~15~H~23~F~3~N~2~O~3~: C, 53.56; H, 6.89; N, 8.33. Found: C, 53.24; H, 6.91; N, 8.57.

### *tert*-Butyl 1-(2,2,2-trifluoroacetyl)-1,7-diazaspiro\[4.5\]decane-7-carboxylate (**20r**) {#sec4.9.11}

Yield = 53.38 g, 69%, colorless oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 4.24--3.56 (m, 4H), 2.88 (td, *J* = 13.0, 4.5 Hz, 1H), 2.71 (br m, 1H), 2.03 (br m, 3H), 1.59 (br m, 5H), 1.45 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 155.5 (q, *J* = 36.0 Hz), 154.6, 116.1 (q, *J* = 289.0 Hz), 79.7, 67.3, 48.7 (q, *J* = 4.1 Hz), 47.1, 42.9, 34.3, 31.2, 28.4, 23.7, 23.1. ^19^F NMR (470 MHz, chloroform-*d*) δ −72.8. EIMS, 70 eV, *m*/*z* (rel. int.): 336 \[M\]^+^ (1); 280 (14); 263 (16); 236 (11); 235 (19); 140 (11); 110 (15); 96 (100); 57 (43); 41 (25); 39 (10). Anal calcd for C~15~H~23~F~3~N~2~O~3~: C, 53.56; H, 6.89; N, 8.33. Found: C, 53.42; H, 7.13; N, 8.62.

### *tert*-Butyl 4-azaspiro\[2.4\]heptane-4-carboxylate (**20a**) {#sec4.9.12}

Yield = 105.0 g, 95%, colorless oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 3.49 (t, *J* = 6.2 Hz, 2H), 1.84 (m, 4H), 1.54 (br m, 2H), 1.41 (s, 9H), 0.41 (m, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.1, 79.0, 48.5, 42.6, 36.9, 28.5, 22.6, 9.1. EIMS, 70 eV, *m*/*z* (rel. int.): 197 \[M\]^+^ (1); 141 (52); 140 (13); 124 (14); 97 (30); 96 (91); 69 (12); 68 (11); 57 (100); 56 (10); 41 (49); 39 (16). Anal calcd for C~11~H~19~NO~2~: C, 66.97; H, 9.71; N, 7.10. Found: C, 67.36; H, 9.86; N, 6.82.

General Procedure xi {#sec4.10}
--------------------

Pd/C (10%, 7.25 g) was added to solution of Cbz-protected amine **11** (0.3 mol) in MeOH (1000 mL). The reaction mixture was hydrogenated at 1 atm of H~2~ until the disappearance of the starting material. The catalyst was filtered and washed with MeOH (2 × 100 mL), and saturated HCl/MeOH solution (400 mL) was added. The solvent was removed in vacuo. The desired product was dried in vacuo.

In the case of **1n**, starting Cbz-amine **11n** (0.166 mol) was dissolved in MeOH (800 mL), and Pd/C (5.35 g) was added. The reaction mixture was stirred overnight in an atmosphere of H~2~ (1 atm). The catalyst was filtered and washed with MeOH (268 mL), and the solution was evaporated. The obtained residue was dissolved in diethyl ether (535 mL) and treated with dioxane/HCl (270 mL). The white solid was filtered and dried in vacuo.

### 5-Azaspiro\[3.4\]octane hydrochloride (**1b**·HCl) {#sec4.10.1}

Yield = 54.8 g, 95%, white solid (mp = 131--133 °C, dec.).

### 1-Azaspiro\[4.5\]decane hydrochloride (**1d**·HCl) {#sec4.10.2}

Yield = 38.4 g, 95%, white solid (mp = 113--115 °C, dec.).

### 8-Oxa-1-azaspiro\[4.5\]decane hydrochloride (**1e**·HCl) {#sec4.10.3}

Yield = 31.39 g, 93%, white solid (mp = 181--184 °C, dec.).

### 8,8-Difluoro-1-azaspiro\[4.5\]decane hydrochloride (**1o**·HCl) {#sec4.10.4}

Yield = 49.79 g, 96%, white solid (mp = 134--136 °C, dec.).

^1^H NMR (500 MHz, DMSO-*d*~6~) δ 9.55 (s, 2H), 3.22 (m, 2H), 2.16 (m, 2H), 2.02--1.90 (m, 6H), 1.90--1.80 (m, 4H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 123.1 (t, *J* = 240.6 Hz), 64.4, 43.0, 33.8, 29.9 (t, *J* = 24.5 Hz), 29.6 (t, *J* = 5.1 Hz), 21.8. ^19^F NMR (470 MHz, DMSO-*d*~6~) δ −96.4. EIMS, 70 eV, *m*/*z* (rel. int.): 175 \[M--Cl\]^+^ (17); 96 (100); 83 (26); 82 (18). Anal calcd for C~9~H~16~ClF~2~N: C, 51.07; H, 7.62; N, 6.62; Cl, 16.75. Found: C, 51.41; H, 7.52; N, 6.82; Cl, 16.72.

### 7-Thia-1-azaspiro\[4.5\]decane 7,7-dioxide hydrochloride (**1n**·HCl) {#sec4.10.5}

Yield = 34.48 g, 92%, white solid (mp = 260--261 °C, dec.).

^1^H NMR (400 MHz, deuterium oxide) δ 4.66 (s, 2H), 3.63--3.60 (m, 1H), 3.50--3.45 (m, 1H), 3.36 (m, 2H), 3.20 (t, *J* = 6.6 Hz, 2H), 2.23--2.10 (m, 2H), 2.09--1.97 (m, 5H), 1.87 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 66.9, 54.2, 49.1, 44.9, 36.4, 30.2, 21.1, 19.0. LCMS, positive mode, *m*/*z*: 190.2 \[M--Cl\]^+^. Anal calcd for C~8~H~16~ClNO~2~S: C, 42.57; H, 7.14; N, 6.21; S, 14.20; Cl, 15.70. Found: C, 42.47; H, 7.12; N, 6.41; S, 14.07; Cl, 15.89.

### (*R*)-7-Thia-1-azaspiro\[4.5\]decane 7,7-dioxide hydrochloride (**1n**(*R*)·HCl) {#sec4.10.6}

\[α\]~D~^21^ = −0.84° (*c* = 0.5, H~2~O).

### (S)-7-Thia-1-azaspiro\[4.5\]decane 7,7-dioxide hydrochloride (**1n**(*S*)·HCl) {#sec4.10.7}

\[α\]~D~^21^ = 0.84° (*c* = 0.5, H~2~O).

General Procedure xii {#sec4.11}
---------------------

Compound **11m** or **20k** (0.5 mol) was dissolved in acetonitrile (1800 mL). Sodium periodate (1.0 mol, 214 g) in water (3300 mL) was added. A catalytic amount (0.1--0.2 mol %) of RuCl~3~ was added. The reaction mixture was stirred for 1 h at rt. The reaction mixture was filtered through a layer of SiO~2~, and acetonitrile was evaporated. The aqueous layer was extracted with ethyl acetate (5 × 430 mL). The organic layer was dried over Na~2~SO~4~ and evaporated. The product was used in the next step without additional purification. The analytical sample was purified by flash column chromatography.

### *tert*-Butyl 7-thia-1-azaspiro\[4.4\]nonane-1-carboxylate 7,7-dioxide (**20l**) {#sec4.11.1}

Yield = 129.40 g, 94%, white powder (mp = 76--77 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 3.84 (d, *J* = 13.0 Hz, 1H), 3.73--3.54 (m, 1H), 3.51--3.31 (m, 2H), 3.06 (dt, *J* = 13.2, 6.9 Hz, 1H), 2.93 (td, *J* = 18.0, 16.1, 9.3 Hz, 1H), 2.77 (d, *J* = 13.0 Hz, 1H), 2.40--2.26 (m, 1H), 2.12 (dt, *J* = 14.0, 7.4 Hz, 1H), 1.96 (m, 1H), 1.91--1.84 (m, 1H), 1.77 (q, *J* = 9.3 Hz, 1H), 1.48 (d, *J* = 39.1 Hz, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.4, 152.9\*, 81.7\*, 80.2, 64.4, 64.3\*, 58.0\*, 56.3, 52.1\*, 51.7, 48.1\*, 47.7, 41.7\*, 41.2, 34.1\*, 33.6, 28.6\*, 28.4, 22.6, 21.8\* (\*due to hindered rotation). LCMS, positive mode, *m*/*z*: 298.2 \[M + Na\]^+^. Anal calcd for C~12~H~21~NO~4~S: C, 52.34; H, 7.69; N, 5.09; S, 11.64. Found: C, 51.96; H, 7.40; N, 5.30; S, 11.62.

### Benzyl 7-thia-1-azaspiro\[4.5\]decane-1-carboxylate 7,7-dioxide (**11n**) {#sec4.11.2}

Yield = 53.54 g, 89%, white solid (mp = 101--102 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 7.35 (s, 5H), 5.10 (s, 2H), 3.60--3.44 (m, 2H), 3.06--2.88 (m, 3H), 2.80 (d, *J* = 14.1 Hz, 1H), 2.72--2.61 (m, 1H), 2.53 (m, 1H), 2.14--1.93 (m, 3H), 1.83 (q, *J* = 7.0 Hz, 2H), 1.59 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 153.9, 136.5, 128.5, 128.1, 127.8, 66.6, 63.9, 56.4, 50.7, 47.6, 35.6, 31.8, 22.3, 19.9. LCMS, positive mode, *m*/*z*: 324 \[M + H\]^+^. Anal calcd for C~16~H~21~NO~4~S: C, 59.42; H, 6.54; N, 4.33; S, 9.91. Found: C, 59.63; H, 6.29; N, 4.01; S, 9.82.

General Procedure xiii {#sec4.12}
----------------------

Ethylcarbamate (0.50 mol, 47 mL) and trimethyl allyl silane (0.58 mol, 48 mL) were added to a solution of ketone **2** (0.50 mol) in dry CH~2~Cl~2~ (1000 mL). The reaction mixture was cooled to 0 °C, and BF~3~·Et~2~O (0.5 mol, 82 mL) was added dropwise for 30 min. The mixture was further stirred at 0 °C for 1 h and overnight at rt. A saturated aqueous solution of NaHCO~3~ (1000 mL) was added carefully. The layers were separated; the organic layer was washed with water (250 mL), dried over Na~2~SO~4~, filtered, and evaporated. The residue was purified by column chromatography (H/EA = 9:1) to give the desired product.

### Ethyl (4-allyltetrahydro-2*H*-thiopyran-4-yl)carbamate (**12f**) {#sec4.12.1}

Yield = 77.98 g, 68%, colorless oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 5.72 (m, 1H), 5.16--5.01 (m, 2H), 4.36 (s, 1H), 4.05 (m, 2H), 2.78 (m, 2H), 2.45 (q, *J* = 5.5 Hz, 4H), 2.30 (d, *J* = 12.3 Hz, 2H), 1.71 (m, 2H), 1.23 (dt, *J* = 14.0, 6.6 Hz, 3H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.2, 132.2, 118.4, 59.9, 53.0, 42.6, 35.3, 23.1, 14.1. EIMS, 70 eV, *m*/*z* (rel. int.): 229 \[M\]^+^ (2); 189 (10); 188 (100); 154 (12); 142 (10); 116 (14); 99 (26); 82 (15); 41 (11). Anal calcd for C~11~H~19~NO~2~S: C, 57.61; H, 8.35; N, 6.11; S, 13.98. Found: C, 57.97; H, 8.64; N, 6.23; S, 13.84.

### Ethyl (3-allyltetrahydro-2*H*-thiopyran-3-yl)carbamate (**12m**) {#sec4.12.2}

Yield = 87.15 g, 76%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 5.69 (m, 1H), 5.11--4.97 (m, 3H), 4.01 (q, *J* = 7.1 Hz, 2H), 2.87--2.78 (m, 1H), 2.66--2.54 (m, 2H), 2.42 (m, 2H), 2.33--2.24 (m, 1H), 2.16 (d, *J* = 14.1 Hz, 1H), 1.75 (m, 2H), 1.23 (m, 1H), 1.18 (t, *J* = 7.1 Hz, 3H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 154.9, 132.9, 118.6, 60.2, 51.7, 42.4, 37.3, 33.5, 28.0, 23.1, 14.6. EIMS, 70 eV, m/z (rel. int.): 229 \[M\]^+^ (5); 188 (74); 142 (37); 141 (17); 140 (100); 116 (10); 112 (10); 99 (46); 96 (11); 82 (16); 80 (14); 79 (11); 45 (10); 41 (22); 39 (13). Anal calcd for C~11~H~19~NO~2~S: C, 57.61; H, 8.35; N, 6.11; S, 13.98. Found: C, 57.36; H, 8.71; N, 6.42; S, 14.24.

General Procedure xiv {#sec4.13}
---------------------

KOH (2.1 mol, 118 g) and hydrazine monohydrate (1.2 mol, 62 mL) were added to a solution of protected amine **15** (0.15 mol) in ethyleneglycol (510 mL). The reaction mixture was heated to 155 °C and stirred for 72 h. Then reaction mixture was cooled to rt, diluted with water (720 mL), and extracted with CH~2~Cl~2~ (4 × 320 mL). The organic layer was dried over Na~2~SO~4~ and evaporated. The residue was dissolved in ethylacetate (100 mL) with further slow addition of saturated HCl solution in ethylacetate (80 mL). The mixture was cooled to 0 °C and stirred for 30 min. The white solid was filtered, washed with ethylacetate, and dried in vacuo.

### 8-Thia-1-azaspiro\[4.5\]decane hydrochloride (**1f**·HCl) {#sec4.13.1}

Yield = 20.34 g, 70%, white solid (mp = 179--181 °C, dec.). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 9.31 (s, 2H), 3.18 (s, 2H), 2.80--2.56 (m, 4H), 2.06--1.87 (m, 6H), 1.86--1.76 (m, 2H). ^13^C{^1^H} NMR (126 MHz, deuterium oxide) δ 66.5, 43.6, 34.4, 32.6, 24.1, 21.8. EIMS, 70 eV, *m*/*z* (rel. int.): 157 \[M--Cl\]^+^ (4); 129 (50); 96 (100); 84 ( 43); 83 (17); 41 (10). Anal calcd for C~8~H~16~NSCl: C, 49.60; H, 8.32; N, 7.23. Found: C, 49.79; H, 8.61; N, 7.63; S, 16.68; Cl, 18.41.

### 7-Thia-1-azaspiro\[4.5\]decane hydrochloride (**1m**·HCl): {#sec4.13.2}

Yield = 24.76 g, 71%, white solid (mp = 160--163 °C, dec.). ^1^H NMR (400 MHz, deuterium oxide) δ H4.66 (s, 1H), 3.26 (t, *J* = 6.9 Hz, 2H), 2.85--2.60 (m, 2H), 2.60--2.40 (m, 1H), 2.07--1.78 (m, 6H), 1.74 (s, 2H); the protons of the NH group are not observed due to the exchange. ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 65.3, 44.2, 35.7, 34.0, 33.2, 26.4, 23.8, 21.7. LCMS, positive mode, *m*/*z*: 158.2 \[M--Cl\]^+^. Anal calcd for C~8~H~16~ClNS: C, 49.60; H, 8.32; N, 7.23; S, 16.55; Cl, 18.30. Found: C, 49.52; H, 8.26; N, 7.23; S, 16.32; Cl, 17.95.

General Procedure xv {#sec4.14}
--------------------

Ketone **2** (0.50 mol) was dissolved in a saturated solution of ammonia in MeOH (870 mL) and stirred for 20 min. Allyl pinacol boronate (0.80 mol, 120 mL) was added dropwise for 15 min. The reaction mixture was stirred at rt overnight. Then, MeOH was evaporated, and 1 M solution of HCl (300 mL) was added carefully. The solution was extracted with CH~2~Cl~2~ (300 mL). The water layer was basified with NaOH solution (until pH = 10) and extracted with CH~2~Cl~2~ (3 × 200 mL). The organic layer obtained was washed with brine (200 mL), dried over Na~2~SO~4~, and evaporated.

In the case of compounds **16p** and **16r**, ketone **2** (0.50 mol) was added into methanolic ammonia (1500 mL, *w* = 20%) and stirred for 20 min at rt. Allyl pinacol boronate (0.625 mol, 94 mL) was added, and the solution was stirred overnight. The solvent was evaporated under reduced pressure, and 10% citric acid solution (1500 mL) was added and washed with CH~2~Cl~2~ (3 × 375 mL). A solution of NaOH (20%) was added until the water layer became alkaline (pH = 10). The water solution was extracted with CH~2~Cl~2~ (3 × 375 mL). The combined organic layer was washed with water (4 × 375 mL), dried over Na~2~SO~4~, and evaporated.

### 4-Allyltetrahydro-2*H*-thiopyran-4-amine (**16f**) {#sec4.14.1}

Yield = 61.34 g, 78%, yellow oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 5.77 (m, 1H), 5.12--4.99 (m, 2H), 2.79 (m, 2H), 2.43 (m, 2H), 2.05 (d, *J* = 7.4 Hz, 2H), 1.70 (m, 2H), 1.60 (m, 2H), 1.01 (s, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 133.0, 118.9, 49.5, 48.1, 39.1, 24.1. LCMS, positive mode, *m*/*z*: 158 \[M + H\]^+^. Anal calcd for C~8~H~15~NS: C, 61.09; H, 9.61; N, 8.91; S, 20.38. Found: C, 61.08; H, 9.76; N, 9.25; S, 20.70.

### 3-Allyltetrahydrothiophen-3-amine (**16k**) {#sec4.14.2}

Yield = 58.02 g, 81%, light yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 5.88--5.72 (m, 1H), 5.21--5.00 (m, 2H), 2.95--2.70 (m, 3H), 2.48 (d, *J* = 10.6 Hz, 1H), 2.29 (d, *J* = 6.9 Hz, 2H), 1.86--1.68 (m, 2H), 1.49 (s, 2H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 134.0, 118.0, 63.4, 44.4, 43.6, 42.6, 28.8. EIMS, 70 eV, *m*/*z* (rel. int.): 145 (2); 144 \[M + H\]^+^ (4); 143 \[M\]^+^ (36); 102 (100); 100 (13); 96 (73); 85 (32); 82 (50); 69 (30); 68 (13); 57 (11); 56 (17); 54 (13); 42 (22); 41 (23); 39 (19). Anal calcd for C~7~H~13~NS: C, 58.69; H, 9.15; N, 9.78; S, 22.38. Found: C, 58.30; H, 8.94; N, 9.83; S, 22.41.

### *tert*-Butyl 4-allyl-4-aminopiperidine-1-carboxylate (**16p**) {#sec4.14.3}

Yield = 110.56 g, 92%, yellow oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 5.82 (m, 1H), 5.17--5.05 (m, 2H), 3.68--3.58 (m, 2H), 3.25 (m, 2H), 2.12 (d, *J* = 7.5 Hz, 2H), 1.50 (m, 3H), 1.44 (s, 9H), 1.33 (dt, *J* = 13.6, 3.9 Hz, 2H), 1.25--1.21 (m, 1H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.8, 133.1, 119.0, 79.3, 49.3, 48.0, 39.7, 37.5, 28.4. EIMS, 70 eV, *m*/*z* (rel. int.): 199 \[M--(CH~2~---CH=CH~2~)\]^+^ (50); 167 (17); 143 (100); 126 (20); 82 (73); 70 (50); 57 (85); 57 (25); 45 (16); 43 (30); 41 (50); 40 (22). Anal calcd for C~13~H~24~N~2~O~2~: C, 64.97; H, 10.07; N, 11.66. Found: C, 65.34; H, 10.19; N, 11.47.

### *tert*-Butyl 3-allyl-3-aminopiperidine-1-carboxylate (**16r**) {#sec4.14.4}

Yield = 110.56 g, 92%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 5.89--5.74 (m, 1H), 5.14--5.03 (m, 2H), 3.26 (d, *J* = 71.9 Hz, 4H), 2.09 (qd, *J* = 13.5, 7.2 Hz, 2H), 1.63--1.45 (m, 4H), 1.41 (d, *J* = 2.3 Hz, 9H), 1.25--1.14 (m, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 155.1, 133.1, 119.0, 79.5, 50.2, 43.5, 36.7, 28.4, 24.7, 24.6, 21.6. LCMS, positive mode, m/z: 241.2 \[M + H\]^+^. Anal calcd for C~13~H~24~N~2~O~2~: C, 64.97; H, 10.07; N, 11.66. Found: C, 65.14; H, 10.27; N, 11.82.

General Procedure xvi {#sec4.15}
---------------------

Amine **16** (0.39 mol) was dissolved in CH~2~Cl~2~ (930 mL) under an argon atmosphere, triethylamine (0.47 mol, 35 mL) was added, and the reaction mixture was cooled to 0 °C. A solution of Boc~2~O (0.39 mmol, 81 mL) in CH~2~Cl~2~ (150 mL) was added dropwise for 15 min. The mixture was stirred at rt overnight, washed with 10% aq citric acid (2 × 300 mL) and brine (300 mL), dried over Na~2~SO~4~, and evaporated.

### *tert*-Butyl (4-allyltetrahydro-2*H*-thiopyran-4-yl)carbamate (**17f**) {#sec4.15.1}

Yield = 95.36 g, 95%, colorless oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 5.80--5.69 (m, 1H), 5.09 (m, 2H), 4.20 (s, 1H), 2.87--2.75 (m, 2H), 2.45 (d, *J* = 8.5 Hz, 4H), 2.29 (d, *J* = 13.8 Hz, 2H), 1.75--1.64 (m, 2H), 1.43 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.3, 132.8, 118.8, 53.3, 43.1, 35.8, 28.4, 27.4, 23.5. EIMS, 70 eV, *m*/*z* (rel. int.): 377 (2); 333 (2); 301 (1); 283 (1); 269 (1); 257 \[M\]^+^ (92); 239 (2); 230 (1); 216 (23); 160 (62); 116 (100); 96 (10); 82 (15); 58 (67); 57 (12); 44 (10); 41 (35); 39 (16). Anal calcd for C~13~H~23~NO~2~S: C, 60.66; H, 9.01; N, 5.44; S, 12.46. Found: C, 60.41; H, 8.95; N, 5.80; S, 12.74.

### *tert*-Butyl (3-allyltetrahydrothiophen-3-yl)carbamate (**17k**) {#sec4.15.2}

Yield = 97.35 g, 100%, white powder (mp = 51--52 °C). ^1^H NMR (40 0 MHz, chloroform-*d*) δ 5.84--5.69 (m, 1H), 5.11--5.02 (m, 2H), 4.58 (s, 1H), 2.89--2.74 (m, 5H), 2.50 (dd, *J* = 14.1, 7.7 Hz, 2H), 1.74 (m, 1H), 1.39 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.5, 133.8, 118.5, 79.3, 65.6, 40.9, 39.5, 39.1, 28.6, 28.4. EIMS, 70 eV, *m*/*z* (rel. int.): 250 (2); 243 \[M\]^+^ (2); 235 (2); 227 (2); 128 (10); 127 (15); 126 (100); 102 (26); 96 (15); 85 (14); 57 (62); 56 (10); 41 (37); 39 (18). Anal calcd for C~12~H~21~NO~2~S: C, 59.22; H, 8.70; N, 5.76; S, 13.17. Found: C, 58.94; H, 8.33; N, 5.58; S, 13.57.

General Procedure xvii {#sec4.16}
----------------------

Boc-protected amine **20** (0.20 mol) was dissolved in MeOH/HCl (245 mL) or dioxane/HCl (1300 mL) for **1f**, **1k**, or **1l**, respectively, and stirred overnight at rt. Then, the reaction mixture was evaporated and treated with Et~2~O, and the solid was filtered and washed with Et~2~O to give the desired product as a hydrochloride salt.

### 8-Thia-1-azaspiro\[4.5\]decane hydrochloride (**1f**·HCl) {#sec4.16.1}

Yield = 36.81 g, 95%, white solid (mp = 179--181 °C, dec.).

### 7-Thia-1-azaspiro\[4.4\]nonane hydrochloride (**1k**·HCl) {#sec4.16.2}

Yield =44.48 g, 99%, white powder (mp = 127--129 °C, dec.). ^1^H NMR (400 MHz, deuterium oxide) δ 4.66 (d, *J* = 2.3 Hz, 2H), 3.30 (t, *J* = 6.3 Hz, 2H), 3.00--2.88 (m, 3H), 2.84 (m, 1H), 2.36--2.22 (m, 1H), 2.12 (m, 1H), 2.04 (m, 4H). ^13^C{^1^H} NMR (126 MHz, deuterium oxide) δ 76.5, 45.1, 38.5, 37.9, 32.9, 27.6, 23.1. LCMS, positive mode, *m*/*z*: 144 \[M--Cl\]^+^. Anal calcd for C~7~H~14~ClNS: C, 46.78; H, 7.85; N, 7.79; S, 17.84; Cl, 19.73. Found: C, 46.87; H, 7.58; N, 7.84; S, 18.19; Cl, 19.5.

### 7-Thia-1-azaspiro\[4.4\]nonane 7,7-dioxide hydrochloride (**1l**·HCl) {#sec4.16.3}

Yield = 97.51 g, 98%, white powder (mp = 204--205 °C, dec.). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 10.06 (s, 2H), 3.74 (d, *J* = 14.2 Hz, 1H), 3.59--3.46 (m, 2H), 3.39--3.16 (m, 3H), 2.64 (dt, *J* = 14.4, 7.3 Hz, 1H), 2.38 (dt, *J* = 14.8, 7.9 Hz, 1H), 2.15--1.89 (m, 4H). ^13^C{^1^H} NMR (126 MHz, DMSO-*d*~6~) δ 67.8, 57.2, 50.8, 44.0, 36.3, 31.5, 22.1. LCMS, positive mode, *m*/*z*: 176.0 \[M--Cl + H\]^+^. Anal calcd for C~7~H~14~ClNO~2~S: C, 39.72; H, 6.67; N, 6.62; S, 15.14; Cl, 16.75. Found: C, 39.37; H, 6.90; N, 6.58; S, 15.45; Cl, 17.12.

### 4-Azaspiro\[2.4\]heptane hydrochloride (**1a**·HCl) {#sec4.16.4}

Yield = 61.5 g, 92%, beige solid (mp = 80--81 °C, dec.). ^1^H NMR (400 MHz, DMSO-*d*~6~) δ 9.53 (s, 2H), 3.23 (p, *J* = 6.4 Hz, 2H), 2.06--1.93 (m, 2H), 1.89 (t, *J* = 7.1 Hz, 2H), 1.17 (t, *J* = 6.4 Hz, 2H), 0.82--0.73 (m, 2H). ^13^C{^1^H} NMR (126 MHz, deuterium oxide) δ 46.4, 42.6, 30.8, 23.5, 9.4. LCMS, positive mode, *m*/*z*: 98 \[M--Cl\]^+^. Anal calcd for C~6~H~12~ClN: C, 53.93; H, 9.05; N, 10.48; Cl, 26.53. Found: C, 53.76; H, 9.16; N, 10.57; Cl, 26.66.

General Procedure xviii {#sec4.17}
-----------------------

In the case of compounds **17p** and **17r**, starting amine **16** (0.46 mol) and triethylamine (0.69 mol, 51 mL) were added to 1660 mL of CH~2~Cl~2~, and the mixture was cooled to −15 °C. Trifluoroacetic acid anhydride (0.55 mol, 175 mL) was added dropwise over 1 h. Then, the reaction mixture was stirred overnight at rt. The reaction mixture was washed with 10% solution of citric acid (400 mL), dried over Na~2~SO~4~, and evaporated. The residue was purified by flash column chromatography to give targeted product **17**.

### *tert*-Butyl 4-allyl-4-(2,2,2-trifluoroacetamido)piperidine-1-carboxylate (**17p**) {#sec4.17.1}

Yield =146.98 g, 95%, yellow oil. ^1^H NMR (500 MHz, chloroform-*d*) δ 5.93 (s, 1H), 5.70 (m, 1H), 5.21--5.07 (m, 2H), 3.76 (m, *J* = 21.8 Hz, 2H), 3.06 (t, *J* = 11.3 Hz, 2H), 2.57 (s, 2H), 2.13 (s, 2H), 1.64 (m, 2H), 1.45 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 156.5 (q, *J* = 36.3 Hz), 154.6, 131.3, 120.1, 115.47 (q, *J* = 289.5 Hz), 79.9, 55.9, 41.1, 39.3, 33.6, 28.4. ^19^F NMR (470 MHz, chloroform-*d*) δ −76.0. LCMS, positive mode, *m*/*z*: 359 \[M + Na\]^+^. LCMS, negative mode, *m*/*z* (rel. int.): 336 \[M\]^−^ (15); 335 \[M--H\]^−^ (100). Anal calcd for C~15~H~23~F~3~N~2~O~3~: C, 53.56; H, 6.89; N, 8.33. Found: C, 53.62; H, 6.93; N, 8.09.

### *tert*-Butyl 3-allyl-3-(2,2,2-trifluoroacetamido)piperidine-1-carboxylate (**17r**) {#sec4.17.2}

Yield = 139.25 g, 90%, yellow solid (mp =94--95 °C). ^1^H NMR (500 MHz, chloroform-*d*) δ 6.20 (s, 1H), 5.72 (m, 1H), 5.15 (dd, *J* = 24.1, 13.5 Hz, 2H), 4.21 (s, 1H), 4.02 (d, *J* = 13.6 Hz, 1H), 2.92--2.73 (m, 3H), 2.63 (s, 1H), 2.23 (s, 1H), 1.57 (d, *J* = 11.7 Hz, 3H), 1.47 (d, *J* = 1.6 Hz, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 156.6 (q, *J* = 35.8 Hz), 154.3, 131.1, 119.9, 115.5 (q, *J* = 289.2 Hz), 80.9, 57.7, 51.6, 45.6, 39.9, 31.0, 28.1, 21.8. ^19^F NMR (470 MHz, chloroform-*d*) δ −76.1, −76.3. LCMS, positive mode, *m*/*z*: 359.2 \[M + Na\]^+^. LCMS, negative mode, *m*/*z*: 335.2 \[M--H\]^−^. Anal calcd for C~15~H~23~F~3~N~2~O~3~: C, 53.56; H, 6.89; N, 8.33. Found: C, 53.54; H, 6.50; N, 8.40.

General Procedure xix {#sec4.18}
---------------------

*N*-Trifluoroacetyl-protected amine **20** (0.23 mol) was dissolved in dry MeOH (1160 mL). NaOH (0.46 mol, 18.4 g) was added by portions. The reaction mixture was stirred overnight, washed with water, dried over Na~2~SO~4~, and evaporated.

### *tert*-Butyl 1,8-diazaspiro\[4.5\]decane-8-carboxylate (**1p**) {#sec4.18.1}

Yield = 51.96 g, 94%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 3.50 (m, 2H), 3.36--3.27 (m, 2H), 2.96 (t, *J* = 6.9 Hz, 2H), 1.91 (s, 1H), 1.78 (p, *J* = 7.1 Hz, 2H), 1.56 (t, *J* = 7.6 Hz, 2H), 1.53--1.46 (m, 4H), 1.43 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 154.8, 79.4, 60.3, 45.4, 41.5, 37.2, 36.5, 28.5, 25.2. EIMS, 70 eV, *m*/*z* (rel. int.): 240 \[M\]^+^; 184 (10); 183 (59); 167 (14); 139 (41); 97 (16); 96 (79); 95 (15); 84 (24); 83 (49); 82 (30); 57 (43); 56 (62); 55 (24); 50 (10); 44 (50); 42 (11); 41 (100); 40 (17); 39 (64); 38 (10). Anal calcd for C~13~H~24~N~2~O~2~: C, 64.97; H, 10.07; N, 11.66. Found: C, 65.31; H, 10.30; N, 11.57.

### *tert*-Butyl 1,7-diazaspiro\[4.5\]decane-7-carboxylate (**1r**) {#sec4.18.2}

Yield = 36.92 g, 96%, yellow oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 3.60--2.85 (m, 6H), 1.83--1.73 (m, 4H), 1.62 (tt, *J* = 12.2, 6.8 Hz, 2H), 1.53 (m, 3H), 1.41 (s, 9H). ^13^C{^1^H} NMR (126 MHz, chloroform-*d*) δ 155.2, 79.4, 60.6, 52.9, 45.6, 43.4, 37.3, 34.1, 28.5, 25.1, 23.3. LCMS, positive mode, *m*/*z*: 241.2 \[M + H\]^+^. Anal calcd for C~13~H~24~N~2~O~2~: C, 64.97; H, 10.07; N, 11.66. Found: C, 64.80; H, 10.08; N, 11.79.

General Procedure xx {#sec4.19}
--------------------

A freshly prepared solution of lithium diisopropylamide (2.4 mol) in THF (2800 mL) was cooled to −80 °C. A solution of *tert*-butyl cyclopropanecarboxylate **21a** (2 mol) in THF (100 mL) was slowly added dropwise for 10 min. The resulting solution was stirred at −80 °C for 5.5 h. A solution of allyl bromide (4 mol) in THF (1400 mL) was slowly added dropwise for 10 min. The solution was allowed to warm slowly from −80 to 0 °C for 4.5 h, and the obtained solution was removed from the cooling bath and quenched by addition of a saturated aqueous solution of NH~4~Cl (1700 mL). The aqueous phase was extracted with diethyl ether (2 × 1400 mL). The combined organic phases were washed with brine (1400 mL), dried over Na~2~SO~4~, filtered, and concentrated in vacuo. The residue was distilled in vacuo (bp = 25 °C, 0.75 mmHg).

### *tert*-Butyl 1-allylcyclopropanecarboxylate (**22a**) {#sec4.19.1}

Yield = 295.3 g, 81%, colorless oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 5.85 (m, 1H), 5.06--4.96 (m, 2H), 2.27 (d, *J* = 6.7 Hz, 2H), 1.42 (s, 9H), 1.12 (q, *J* = 4.0 Hz, 2H), 0.64 (q, *J* = 4.0 Hz, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 174.1, 136.0, 115.9, 80.0, 37.5, 28.0, 23.4, 14.6. EIMS, 70 eV, *m*/*z* (rel. int.): 126 \[M--(C(CH~3~)~3~) + H\]^+^ (55); 111 (17); 109 (20); 83 (10); 81 (60); 80 (40); 77 (11); 67 (13); 57 (100); 53 (24); 43 (20); 41 (84); 40 (12); 39 (53). Anal calcd for C~11~H~18~O~2~: C, 72.49; H, 9.95. Found: C, 72.30; H, 9.69.

General Procedure xxi {#sec4.20}
---------------------

A mixture of compound **22a** (1.62 mol) with trifluoroacetic acid (1.94 mol, 330 mL) was refluxed for 2 h. The complete conversion was confirmed by NMR spectroscopy. The reaction mixture was cooled to 5 °C and poured to a diluted (15%) aqueous solution of NaOH to pH = 10. Byproducts were extracted with MTBE (2 × 600 mL), and the aqueous layer was acidified with diluted HCl to pH = 1--2. The target compound was extracted with MTBE (2 × 1800 mL), separated, dried, and evaporated to give the desired product.

### 1-Allylcyclopropanecarboxylic Acid (**23a**) {#sec4.20.1}

Yield = 163.49 g, 80%, colorless oil. ^1^H NMR (400 MHz, chloroform-*d*) δ 12.03 (s, 1H), 5.84 (m, 1H), 5.12--4.89 (m, 2H), 2.30 (d, *J* = 6.7 Hz, 2H), 1.27 (q, *J* = 4.1 Hz, 2H), 0.79 (q, *J* = 4.1 Hz, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 182.3, 135.3, 116.5, 36.7, 22.6, 15.9. EIMS, 70 eV, *m*/*z* (rel. int.): 126 \[M\]^+^ (4); 125 (8); 124 (1); 122 (1); 11 (53); 108 (35); 98 (14); 97 (42); 83 (30); 81 (84); 80 (64); 79 (100); 77 (33); 70 (23); 68 (10); 67 (42); 66 (13); 65 (22); 55 (30); 54 (22); 53 (75); 52 (24); 51 (36); 50 (24); 45 (39); 43 (15); 42 (25); 41 (62); 40 (16); 39 (99); 38 (15). Anal calcd for C~7~H~10~O~2~: C, 66.65; H, 7.99. Found: C, 66.26; H, 7.93.

General Procedure xxii {#sec4.21}
----------------------

A mixture of **23a** (1.30 mol), DPPA (1.55 mol, 545 mL), and Et~3~N (1.55 mol, 115 mL) in *tert*-butyl alcohol (1400 mL) was heated to 80 °C and stirred overnight. The reaction mixture was evaporated, redissolved in EtOAc (1600 mL), and washed with a saturated solution of Na~2~CO~3~ (2 × 600 mL). The organic layer was separated, dried over Na~2~SO~4~, and concentrated. The product after work-up was used in the next step without further purification. The analytical sample was purified by column chromatography.

### *tert*-Butyl(1-allylcyclopropyl)carbamate (**17a**) {#sec4.21.1}

Yield = 197.47 g, 77%, white solid (mp = 41--43 °C). ^1^H NMR (400 MHz, chloroform-*d*) δ 5.84--5.70 (m, 1H), 5.07--4.96 (m, 2H), 4.86 (br s, 1H), 2.25 (d, *J* = 7.2 Hz, 2H), 1.38 (s, 9H), 0.69 (s, 2H), 0.59 (s, 2H). ^13^C{^1^H} NMR (101 MHz, chloroform-*d*) δ 155.5, 135.0, 117.2, 79.1, 40.5, 32.7, 28.3, 12.9. EIMS, 70 eV, *m*/*z* (rel. int.): 141 \[M--(C(CH~3~)~3~) + H\]^+^ (3); 126 (20); 96 \[M--Boc\]^+^ (27); 82 (26); 69 (10); 59 (14); 57 (100); 56 (11); 41 (39); 39 (15). Anal calcd for C~11~H~19~NO~2~: C, 66.97; H, 9.71; N, 7.10. Found: C, 66.72; H, 10.00; N, 7.12.
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